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CHAPTER I 
INTRODUCTION 
1.1. Kidney transplantation and immnnological rejection 
The prime cause of failure of a transplanted kidney is immunological rejection of 
the graft. Graft rejection will not occur, when the transplanted organ is obtained 
from a donor which is genetically identical to the recipient (isogenic transplant). 
Graft rejection can always occur, when donor and recipient are genetically diffe-
rent (allogenic transplant). Unrelated people are always genetically different. 
Only when donor and recipient are monozygotic twins, complete genetic ident-
ity exists. Thus a transplanted organ will be antigenic, when donor and recipient 
are not monozygotic twins. The immune reaction, evoked by the antigens of 
such an allograft, consists of two components. In the first place, antibodies will 
be produced, which are specifically directed against the transplanted antigens 
(the so called humoral immune response). Secondly, immune reactive cells are 
generated, which specifically can attack the transplanted organ (the cellular im-
mune response). The mechanism of the destruction of the allograft is complicat-
ed and only partly known. Both different types of antibodies and different typ-
es of cells are involved. Microscopically, arteritis and a cellular infiltrate can be 
seen (Busch et al., 1977). Progressive damaging of the glomeruli and tubuli 
results in a increasing loss of function of the transplanted kidney. 
Two factors determine the strength of the immune reaction of the recipient 
against the allograft. These factors are the immune response potential of the re-
cipient and the strength of the antigenic stimulus (Lengerova, 1969). The 
strength of the antigenic stimulus is dependent on the immunogenetic differen-
ce between donor and recipient. Consequently, two methods are available to pre-
vent allograft rejection, namely modification of the immune response and select-
ion of compatible donor-recipient pairs. 
1.2. Prevention of the allograft rejection 
1.2. I. Modification of the immune response 
Aspecific suppression of the immune response can be accomplished by the ad-
ministration of drugs, as corticosteroids and azathiopurine. Some clinicians 
advocate a short course of anti-lymphocyte globulin (ALG) in addition (e.g. 
Monaco et al.. 1977). Immunosuppressive drugs have potentially dangerous 
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side-effects. Besides suppression of the immunity against the transplanted 
foreign tissue, the immunity against pathogenic micro-organisms is lowered as 
well. Consequently, local infections and infectious diseases are a feared cause of 
morbidity and mortality for those under immunosuppressive therapy. Another 
complication of long term treatment with immunosuppressive agents is a higher 
incidence of malignant tumours in patients with an allograft (Penn, 1977). 
Specific suppression of the immune response against the transplanted organ 
would be a better form of therapy. The immunity against pathogenic micro-
organisms would be unaffected. Indeed, specific prolonged acceptance of an allo-
graft can be achieved in mouse and rat models (Jeekel, 1971; Marque! et al., 
1971 ). The prolonged acceptance of allografts in these models is probably caus-
ed by enhancement. Enhancement of an allograft is defined as the prolonged 
acceptance of an allograft, due to the presence in the recipient of aBo-antibodies 
directed against the alia-antigens of the donor (Snell, 1970). Enhancing antibod-
ies do not damage but protect the allograft. However, reliable methods to in-
duce enhancement in larger mammals, including man, have not yet been devel-
oped so far. 
1.2.2. Histocompatibility matching 
Selective suppression of the rejection reaction against tissue antigens on the 
transplanted organ, without affecting the general immune status of the recipient, 
is presently not possible in man. Consequently, clinical allotransplantation 
cannot be performed without the use of immunosuppressive drugs. Only in the 
case where the so called transplantation or histocompatibility antigens of the 
donor organ (which provoke the immune response of the host) differ only 
slightly from those of the recipient, can low doses of immunosuppressive drugs 
be used to prevent rejection. Thus, the risk for drug induced diseases should be 
lower, when the donor is compatible for these antigens. Therefore, the selection 
of compatible donor-recipient combinations (histocompatibility matching) is 
another logical approach to improving the prospects of allograft recipients. 
1.3. Major histocompatibility complex 
1.3.1. Genetics 
A variety of different histocompatibility antigens is present on the cells of each 
individual. Some of these antigens (the strong or major histocompatibility anti-
gens) are more likely to elicit a rejection reaction in the host than others (the so 
called weak or minor histocompatibility antigens). The genetic code for all these 
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antigens resides in many genes on different chromosomes. For instance, skin 
graft survival in mice is controlled by at least 29 different genes (Graff and Bail-
ey, 1973 ). However, one particular chromosomal region, which codes for import-
ant histocompatibility antigens, has been identified in many species. This region 
is called the Major Histocompatibility Complex (MHC). 
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Figure l.l. Pedigree of a family with different MHC genotypes. Explanation: see text. 
Extensive knowledge on the genetics of the MHC has been gathered in many 
species including man (for a review see D. Gotze, ed.: The major histocompat-
ibility system in man and animals, 1977). The MHC contains many, maybe 
hundreds of loci. At present, the gene products of only some of these loci can 
be determined. 
In families, the genes of the MHC are inherited as genetic entities which segreg-
ate en bloc. A simplified scheme of the normal inheritance pattern is present-
ed in figure I. The rectangles in the figure present the MHC's of both homo-
logous chromosomes of each individual. The genes of the MHC of one chromo-
some, which segregate together within a family (the rectangle), is called a hap/o-
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type. Thus, each individual has two haplotypes. The haplotypes of the father are 
here labelled A and B, and those of the mother C and D. The possible "geno-
types" of their offspring are AC, AD, BC and .BD. The homologous loci on the 
haplotypes are labelled 1, 2, 3 and 4 in this example. Each locus can be occupied by 
alternative (mutually exclusive) genes or alleles. The number of alleles varies per 
locus, but within a family never more than four alleles are present for each locus. 
For simplicity, in the example of figure 1 the alleles of the series 1, 2, 3 and 4 
are labelled l(A), l(B), l(C), !(D); 2(A), 2(B) etc. It is clear that, when two 
children of the same family have the genotype AC, they will be identical for the 
genes of series 1, 2, 3 and 4 of both haplotypes. When two children are known 
to have 1 (A), then usually both will have also 2(A), 3(A) and 4(A) in common. 
Thus, within a family, matching for one or just a few MHC antigens generally 
results in matching for all MHC antigens of a haplotype. Within a family three MHC 
matches are possible: two individuals can be two haplotypes different (e.g. AC 
and BD); they can be one haplotype different (or "haploidentical", e.g. AC 
and AD), or they can be MHC identical, when they share the determinants of 
both haplotypes (e.g. AC and AC). 
Sometimes this simple "A-B-C-D" pattern of inheritance is disturbed by the 
occurrence of a so called crossing-over between the two homologous chromo-
somes, which carry the MHC. This happens when, during the meiosis of the 
spermatocyte or the oocyte, these chromosomes exchange parts and conse-
quently a new haplotype originates (figure 2). An individual with such a 
recombinant MHC will never be completely MHC identical with its sibs. The 
frequency of the occurrence of such a recombination between two genetic 
markers on one chromosome in a given population is a measure for the dis-
tance between these genes on the chromosome. Thus, when two loci are locat-
ed comparatively far from each other on the same chromosome, a recombin-
ation between them will occur relatively often. If two loci are close to each 
other on the chromosome (closely linked), a recombination will be rare. Within 
the MHC, recombinations are relatively rare. Such recombinations are of inter-
est, as they may be helpful in the mapping of genes within the MHC (e.g. 
Netzel et al., 1975; Bijnen et al., 1975a; 1976). When individuals with such a 
recombination are used in transplantation experiments, it is sometimes pos-
sible to estimate the importance of a particular part of the MHC for graft sur-
vival. Thus, for example, by transplantation experiments in recombinant 
strains of mice the relative importance of the various subregions of the mouse 
MHC with regard to skin graft survival has become fairly accurately known 
(David, 1977). 
Some loci of the MHC are demonstrated to be extremely polymorphic, as 
for each locus a series of many different alleles exists. Within a family how-
ever only four different alleles are present for each locus; identity for one gene 
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of a haplotype is generally accompanied by identity for the other genes of that 
haplotype. Thus, completely MHC matched sibling donor-recipient combinations 
can often be found. The chances to find unrelated compatible donor-recipient 
combinations will be much more dependent on the polymorphism of the impor-
tant histocompatibility systems. 
2 
A/B C 
Figure 1.2. Genotype of an individual with a paternal recombination in the MHC. Explanation: see text. 
1.3.2. Histocompatibility testing 
Two different in vitro techniques for histocompatibility testing will be described 
here: the lymphocytotoxicity test and the mixed lymphocyte reaction. 
1.3.2.1. Testing for SD antigens with the lymphocytotoxicity test 
For this test, sera are required which contain specific antibodies directed against 
histocompatibility antigens. To obtain antisera containing such antibodies two 
sources are available. In the first place alloantisera can be raised by deliberate 
immunization of volunteers. Furthermore, during pregnancy sometimes anti-
bodies are produced which are directed against the antigens of the foetus. Thus 
post-partum sera are another important source of alloantisera (Payne and Rolfs, 
1958; van Rood et al., 1958). All sera have to be analyzed for their specificity. 
Sometimes they contain a mixture of antibodies. Then they have to be purified 
by absorbing out the undesired antibodies. With a set of properly selected anti-
sera random individuals may be tested. 
For this testing generally a complement dependent lymphocytotoxicity me-
thod is used, which takes a couple of hours. Peripheral blood lymphocytes of an 
individual are added to a panel of test sera. If a serum contains cytotoxic anti-
bodies which are directed against antigens of these lymphocytes, then these 
lymphocytes are killed in the presence of complement. After staining with 
eosine or trypan blue the viability of the cells can be assessed under the light 
microscope. Killing of lymphocytes by an antiserum implies that these lympho-
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cytes carry the antigen which is recognized by the specific antiserum. The anti-
gens on lymphocytes recognized by this serological technique are called serologic-
ally defined (SD) antigens, in contrast to the so called lymphocyte defined (LD) 
antigens as described in the next paragraph. 
1.3.2.2. Testing for LD antigens with the mixed lymphocyte reaction 
Under adequate culture conditions lymphocytes can be stimulated by allogeneic 
lymphocytes to proliferate and transform into blasts (Bain et al., 1964; Bach and 
Hirschhorn, 1964 ). This proliferation and blast transformation is associated with 
an increase in the amount of DNA in the cultured cell suspension. The increase 
in DNA can be measured if radioactive labelled thymidine is added to the cul-
ture. Generally this is done a number of hours before the end of the culture 
period which takes several days. The amount of radioactive thymidine which 
is incorporated into the DNA is then a measure for the growth rate at that time. 
The reaction of the lymphocytes in such a mixed lymphocyte culture is called 
the mixed lymphocyte reaction (MLR). 
Before mixing the cell suspensions at the beginning of a culture, the cells of 
one of the suspensions can be pretreated with drugs (or x-irradiated) to prevent 
their growth (Bach and Voynow, !966). If this is done properly, such cells stay 
alive and do not lose their antigenic properties. The pretreated cells are called 
stimulator cells. The advantage of such a pretreatment is that only the cells of 
the non-pretreated suspension, the responder cells, can grow. Thus, in such a 
unilateral MLR, all activity measured is the result of an increase in DNA synthes-
is of the responder cell population. If both cell suspensions are not pretreated, 
the test is called a bilateral MLR. The interpretation of a bilateral mixed lym-
phocyte culture is obviously more difficult, as the contribution of each separate 
cell suspension to the measured activity cannot be determined. 
Measurable reactivity in the MLR means that two individuals differ for a spec-
ial kind of histocompatibility antigens, the MLR antigens. As these antigens are 
recognized by lymphocyte culturing techniques, they are also called lymphocyte 
defined (LD) antigens. 
1.3.3. Matching for gene products of the MHC 
I. 3. 3.1. SD antigens 
After the discovery that anti-leucocyte antibodies sometimes are produced dur-
ing pregnancy (Payne and Rolfs, 1958; van Rood et al., 1958), large amounts 
of reliable alloantisera became available for SD testing. Typing for leucocyte anti-
gens became only feasible after the introduction of the computer assisted ana-
lysis of the reaction patterns of antisera with large panels of leucocytes (van 
Rood, 1962; van Rood and van Leeuwen, 1963 ). 
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In man presently three allelic series of SD antigens are recognized with large 
batteries of well-defined antisera (Thorsby, 1974). They are labelled HLA-A, 
HLA-B and HLA-C. Because of the large number of alleles in each series, theo-
retically millions of phenotypes would be possible if the various antigens of the 
different allelic series would be distributed independently of each other in the 
population. Consequently, matching for the antigens of the MHC would be prac-
tically impossible. However matching is possible as some phenotypes are more fre-
quent than others. There are two reasons why some phenotypes are more frequent 
than others. In the first place, the gene frequencies of some antigens are higher 
than the gene frequencies of other antigens. Combinations of frequent occur-
ring genes will thus also be found more often than other combinations. Second-
ly, some combinations of antigens of different allelic series occur more often 
than expected on the basis of their individual gene frequencies. This non random 
association of certain alleles of different series is called linkage disequilibrium. 
Linkage disequilibrium between genes of different allelic series is well document-
ed in several out bred species, including man, rhesus monkey and dog. Recent in-
formation on the gene frequencies and linkage disequilibria within these species 
is reviewed in D. Gotze, ed.: The major histocompatibility system in man and 
animals (1977). In fact the occurrence of linkage disequilibrium implicates that 
some "haplotypes" (and phenotypes) are rare, while others occur more frequent. 
Therefore, donor-recipient matching may well be practicable for individuals with 
frequent occurring HLA phenotypes. 
1.3.3.2. LD antigens 
The MHC does not only contain the genes which code for the SD antigens, but 
also contains the genetic information which determines the outcome of the 
MLR. SD and LD antigens are proven to be determined by separate loci in seve-
ral species. In man one major MLR locus is recognized (Yunis and Amos, 1971 ). 
Besides this major MLR locus, the MHC probably contains minor MLR loci as 
well (Eijsvoogel et al., 1972; Mempel et al., 1973; Suciu- Foca and Dausset, 
1975; Netzel et al., 1975; Bijnen et al., 1977). 
In the mouse the gene products of even 5 loci within the MHC (Meo et al., 
1973) and one locus outside the MHC, the so called M locus (Festenstein et al., 
1972) are involved in the determination of the outcome of the MLR. Also in 
other species, as the rhesus monkey (Balner et al., 1973), the pig (Vaiman et al., 
1973), the dog (van den Tweel et al., 1974) and the rat (Williams et al., 1977), 
the MLR is controlled by a distinct locus. 
To match for MLR or LD antigens, pairs of individuals can be tested together 
in a mixed lymphocyte culture. The MLR is a direct cross reaction, which meas-
ures the presence or absence of an incompatibility between individuals without 
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typing them. Twenty-five percent of the siblings are compatible for the LD anti-
gens. The polymorphism of LD antigens however makes a chance compatibility 
between random unrelated individuals an extreme rarity. Thus large groups of 
individuals should be cross tested when MLR compatible individuals are looked 
for. 
Theoretically a helpful method for the selection of unrelated MLR negative 
combinations is LD typing, i.e. assigning LD specificities to individuals. LD typ-
ing can be done by means of LD typing cells. Such cells are homozygous for 
LD determinants. They can be obtained from inbred individuals (J¢rgensen et al., 
1973; Keuning et a!., 1975a, Keuning, 197 8). Figure 3 illustrates, by means of an 
example of a brother-sister mating, how such typing cells can be selected. The 
father ("1 ") and the mother ("2") are both heterozygous for the LD antigens 
and have the genotypes AB and CD respectively. In this example, they have two 
children ("3" and "4"), both with the genotype AC. The offspring of a brother-
sister mating of these individuals have the genotypes AA, AC and CC (individuals 
"5", "6" and "7" respectively). Individuals "5" and "7" are LD homozygotes. 
If all individuals of this family are cross tested with each other, an MLR pattern 
will be seen as illustrated in the figure. For simplicity in this example only a 
distinction is made between negative and positive reactions. The homozygous 
individuals "5" (genotype AA) and "7" (CC) can produce a so called one way 
reaction. For instance "5" (AA) does not stimulate other individuals which carry 
the LD type "A", such as "1" (AB) and "3" (AC). These individuals namely re-
cognize the A determinant as "self". In contrast, "5" (AA) is stimulated by "I" 
(AB) and "3" (AC) because they carry LD determinants (Band C respectively), 
which are foreign to "5". With the homozygous cells "5" (AA) and "7" (CC) it 
is possible to type the other members of the family as well. For instance, it can 
be seen from the table that individual "6" should be typed "AC", as he exhibits 
a one way positive reaction with "5" (AA) and "7" (CC). 
When several homozygous typing cells are available, population studies can be 
performed. Specificity numbers can be assigned to different LD typing cells, and 
unrelated individuals can be typed. In practice, not only clearly negative and pos-
itive reactions occur. Sometimes a homozygous typing cell causes a weakly pos-
itive response. Such a weak typing response may also indicate that the respond-
er carries the LD determinant of the typing cell. Unfortunately, LD typing of 
unrelated individuals is hampered by the fact that unrelated individuals can still 
be MLR positive, even if they carry the same LD determinants (van Rood, 1978; 
Keuning, 1978). 
In summary, LD matching (i.e. selection of LD or MLR compatible individ-
uals) can be performed by means of a direct MLR or by means of LD typing. 
Complete LD or MLR identity can only be ascertained with the direct MLR. 
Therefore, in this thesis, with LD or MLR identity is meant that a direet MLR 
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was performed and that the test outcome was completely negative. LD or MLR 
compatibility means that a direct MLR was performed, and that the test out-
come was negative or lowly positive. If LD or MLR compatibility is only ascertain-
ed by means of LD typing, than this is specifically indicated in the text. 
res- Stimulator cells 
ponder 
lx 2x 3x 4x 5x 6x lx AB CD cells 
I '2 
~ + + + + + 2 + + + + + 
AC AC 3 + + 
3 4 
I I 4 + + 
5 + + + + + + 
AA AC cc 6 + + 
5 6 7 
7 + + + + + + 
Figure 1.3. MLR between heterozygous and homozygous family members. Explanation: see text. 
1.4. SD compatibility and human renal allograft survival 
Histocompatibility matching may contribute to improved kidney allogratt surviv-
al rates, improved patient survival rates and a reduced morbidity in renal allo-
graft recipients ( § 1.2.2.). Patient morbidity is difficult to quantitate and little 
knowledge is available on the correlation between morbidity and histocompatibil-
ity match grade. Kidney allograft survival data are presumably a more sensitive 
index for the evaluation of the effect of histocompatibility matching than pa-
tient survival data, as many patients, who reject the transplanted kidney, return 
to dialysis and stay alive. Therefore, kidney allograft survival data are described 
most extensively in the literature; these data will be discussed below. 
1.4.1. Related donors 
Kidney allografts from MHC identical sibimg donors have an excellent prognosis. 
After one year about 85%- 90% of the kidneys are still functioning. This is signif-
icantly better than the one year survival of grafts from parental donors and one 
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haplotype different sibling donors, which is about 70%(65%- 85%) (Singal et al., 
1969; Brynger et al., 1977; Opelz et al., 1977e; Solheim et al., 1977). The one 
year graft survival of kidneys obtained from two haplotype different sibling don-
ors is still worse, namely ± 50% (Opelz et al., 1977e). 
1.4.2. Unrelated donors 
Related individuals are an important source of donor organs, but more than twi-
ce as much of the registered kidney allografts are presently obtained from cada-
ver donors (Human Renal Transplant Registry, 1977). On the whole, the one year 
survival of cadaveric kidney allografts however is only± 50% after one year. At-
tempts to improve renal allograft survival by means of matching donor and recip-
ient for HLA antigens have been less effective in unrelated than in related don-
or-recipient combinations. 
The literature on the precise effect of HLA matching on cadaveric allograft 
prognosis seems contradictory and is at least confusing. In Europe, a significant 
correlation between match grade and graft prognosis is observed in several 
centers (van Hooff et al., 1972; Dausset eta!., 1974; Scandiatransplant report, 
1975; Festenstein et al., 1976; Sachs et al., 1977; Solheim et al., 1977). In these 
centers a one year graft survival of 55%- 70% is found in the full-house matched 
(i.e. matched for two HLA-A and two HLA-B antigens) groups compared to 40%-
57% in the mismatched groups. No significant correlation was initially found by 
some American groups (Belzer et al., 1974; Opelz et al., 1974a). More recently 
a slight but significant influence of HLA matching on functional graft prognosis 
was also reported by Opelz et al. (1977a). Curiously such a favourable effect of 
matching was only seen in centers with poor overall results. 
Some others reported that kidney allograft survival is worse in recipients with 
circulating preformed antileucocyte antibodies (Terasaki et al., 1971; van Hooff 
et al., 1972; Opelz et al., 1972; 1974a and l977a), but others did not find a differ-
ence (Dausset et al., 1974; Ferguson et al., 1977). HLA matching was found to 
be more effective in patients with such circulating cytotoxic antibodies (van Hooff 
et al., 1972; Dausset et al., 1974). However this observation is at variance with a 
recent report of Opelz et al. (1977a), who did not find a difference in effect of 
HLA matching in antibody negative compared to antibody positive recipients. 
Matching for HLA-B antigens rather than for HLA-A antigens seems to impro-
ve renal allograft survival (van Hooff et al., 1972; Oliver et al., 1972; Dausset et 
al., 1974; Sachs et al., 1977), suggesting a greater antigenicity of gene products 
of the HLA-B locus than of the HLA-A locus. Confusingly, others did not record 
a difference in antigenicity between HLA-A and -B antigens (Opelz et al., 1974a; 
1977a; Scandiatransplant report, 1975). 
Finally, van Hooff et al. (1974) and Thompson et al. (1977) found that 
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matching for certain combinations of antigens, which are known to be in strong 
linkage disequilibrium with each other (so called haplotype-matching}, would 
improve cadaveric graft survival rates. They suggested, that because of the high 
linkage disequilibrium of these "haplotypes" with certain LD determinants 
matching for these SD antigens would imply matching for LD antigens as well. 
However, the observed linkage disequilibria are insufficient to explain these re-
sults (van Rood et al., 1975). Furthermore, other similar studies did not con-
firm these data (Scandia transplant Report, 1975; Opelz et al., 1976). 
The cause for the differences in results is unclear. Probably, a different com-
position of the populations under study is in part responsible. However, one 
general conclusion can be drawn, i.e. that common sensus has been reached on 
the statistical significance of HLA matching in human kidney graft survival. Its 
practical significance for the various subsets of patients remains a matter for fur-
ther evaluation. 
1.4.3. Discrepancy in the results of SD matching in related and unrelated donor-
recipient pairs 
HLA identical related grafts have an excellent prognosis of 85% - 90% after one 
year ( § 1.4.1.), while full-house HLA identical cadaveric grafts have a poorer 
prognosis of 55%- 70% after one year ( § 1.4.2.). 
One possible cause for the discrepant survival rates of matched related and un-
related kidney allografts is that matching for cadaveric grafts is only performed 
for the HLA-A and -B antigens. In § 1.3.1. it is explained that matching for the 
defined antigens of the MHC in related donor-recipient combinations implies 
that a good match is obtained for all other undefined gene products of the MHC. 
In unrelated donor-recipient pairs this is not necessarily the case. Thus it is pos-
sible that the MHC contains one locus, different from but in linkage disequili-
brium with the loci typed for, which is very important for graft survival. If this 
is the case, it could explain the differences in survival rates. It would mean fur-
thermore that all efforts should be directed to develop a typing method for the 
gene products of this graft prognosis locus (van Rood et al., 1975). 
The H-2 complex of mice carries at least three different genes which are rele-
vant for skin allograft rejection (Klein, 1975). Thus, a second possible explan-
ation for the discrepancy of the results is that the defined genes each have a histo-
compatibility effect of their own and that some extra loci still have to be identi-
fied. Thus, Opelz et al. (1977b) calculated that each mismatch for an HLA anti-
gen causes a 4% decrease of the one year graft survival. 
A third possibility is that the cumulative effect of non-MHC antigens plays an 
important role. Non-MHC differences are more frequent in unrelated than in 
related donor-recipient pairs. This is another possible explanation for the lower 
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survival rates of cadaver donor kidneys. Opelz et a!. (1977e) calculated that dif-
ferences for these non-MHC antigens are responsible for a rejection rate of 15% 
of the grafts in one year in related donor-recipient combinations. In unrelated 
donor-recipient combinations this figure may even have to be multiplied by two. 
Finally, multiple genes may be involved in the genetic control of kidney allo-
graft survival, some of them concentrated on one chromosomal region (the 
MHC), others located on different chromosomes. 
1.5. LD compatibility and human renal allograft survival 
1.5.1. Related donors 
The incubation time of an MLR is several days. Therefore, a proper prospective 
selection of MLR compatible donor-recipient combinations is impossible in cada-
ver kidney transplantation. Such a prospective study can only be performed with 
living donors. Living donors are mostly related donors. Related donor-recipient 
pairs can be classified as MHC identical, one haplotype different or two haploty-
pes different. Because of the strong linkage between the MLR genes and the 
other genes of the MHC, a reliable estimate of the value of the MLR for donor 
selection can only be made if only one (or two) haplotype different donor-reci-
pient pairs are considered. Thus some publications which suggest a positive cor-
relation between stimulation in MLR and kidney allograft rejection are some-
what difficult to evaluate as the haplotype categories are not clearly taken into 
account in the analysis (Jeannet 1969/1970;Hamburgeret a!., 1971; Segall eta!., 
1975; Uehling eta!., 1977). However, a positive correlation is also found when 
all analyzed donor-recipient pairs are explicitly different for one HLA haplotype 
(Ringden eta!., 1976; Solheim eta!., 1977). 
1.5.2. Unrelated donors 
In the unrelated donor-recipient combinations, i.e. in cadaver kidney transplant-
ation, the situation is somewhat different, as identity for MLR antigens does 
not imply identity for other gene products of the MHC. A positive correlation 
between MLR and graft rejection is observed in some retrospective clinical stu-
dies (Cochrum eta!., 1973; Festenstein eta!., 1976; Opelz and Terasaki, 1977d). 
However, Sachs et a!. (1977) found no statistical significant difference of kid-
ney graft survival in MLR compatible and MLR incompatible HLA-A and -B 
matched unrelated donor-recipient combinations. 
The number of reports on the value of LD matching for donor selection is 
much smaller than the number of reports on the relevance of SD matching for 
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donor selection. However most reports demonstrate that LD compatible grafts 
have a better prognosis than LD incompatible grafts. Thus it seems justifiable to 
pursue the attempts which may enable a prospective identification of LD compat-
ible donor-recipient combinations for cadaver kidney transplantation. 
1.6. LD compatibility and experimental allograft survival 
Research in experimental models can provide additive information on the value 
of tissue typing methods for donor selection. Many studies have been performed 
in various species to assess the role of LD compatibility for different organ allo-
grafts. The results are variable and depend on the experimental model. For in-
stance no correlation is found between allograft survival and reactivity in mixed 
lymphocyte cultures for experimental skin graft survival in rhesus monkeys 
(Bainer and van Vreeswijk, 1975), for kidney graft survival in rats (Fabre and 
Morris, 1974) and graft versus host and host versus graft reactions after bone 
marrow transplantation in dogs (Vriesendorp et a!., 1976). On the other hand 
many publications show a favourable influence of MLR matching on allograft 
survival, for instance for skin graft survival in unrelated human volunteers (Koch 
eta!., 1973) and in related human volunteers (Sasportes eta!., 1972). Such a fav-
ourable effect is also found for kidney graft survival in dogs (M.L. Bach et a!., 
1975; Westbroek eta!., 1975) and rhesus monkeys (vanEs eta!., 1977).1n mice, 
H-2 LD disparity is always associated with graft versus host reactions and often 
(but not always) associated with skin graft rejection (e.g. Bach and van Rood, 
1976). However, the presence of an M locus disparity does not influence skin 
and bone marrow graft survival in MHC identical mice, although the MLR in 
these donor-recipient combinations is positive (Festenstein eta!., 1973). 
The cause for the discrepancy between the reports which deny and which 
support the importance of matching for MLR to allograft survival is unknown. 
The sensitivity of the used techniques may play a role, as well as species specific 
and organ specific differences. It is clear that more work has to be done to ob-
tain a better insight into the role of MLR matching for allograft survival. 
I. 7. The dog as an experimental model for histocompatibility and transplanta-
tion research 
Throughout the years the dog has been a favourable model for transplantation 
experiments, because of its size, ready availability and good temper, which facil-
itates easy handling. In the last decade many investigators started histocompat-
ibility studies in this species because of the growing demands of an immunogen-
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etically defined preclinical experimental out bred animal model. The short generat-
ion time and the large litter sizes of dogs facilitates the breeding of required 
phenotypes for specific immunogenetic purposes and genetic studies. Develop-
ments in this field made international co-operation a necessity. International 
workshops on canine immunogenetics have been organized in 1972 in Rotter-
dam, the Netherlands, and in 1975 in Portland, Oregon, U.S.A .. The "Joint Re-
ports" (1973, 1976) present the accumulated knowledge of the canine MHC and 
other genetic markers in the dog as far as known at that time. 
An extensive review of the present knowledge of the canine MHC is recently 
given by Vriesendorp eta!. (1977b). It appears that the canine MHC closely re-
sembles the MHC in man. Three series of serologically detectable antigens are 
defined, DLA-A, DLA-B and DLA-C with 7, 5 and 3 defined alleles respectively. 
More alleles may be defined in the future, as all series still have "blanks". A high 
linkage disequilibrium exists between the alleles of the three series. The cause for 
this linkage disequilibrium may be a so called "bottleneck" or "founder" effect 
(Vriesendorp, 1973). According to that author, periods and/or areas may have 
existed in dog history, in which only a limited number of animals was available 
for reproduction. The DLA haplotype of these ancestors will be overrepresented 
in the present dog populations. Another consequence of this "founder effect" is 
the limited polymorphism for example of red and white cell enzyme markers in 
this species (Meera Khan et a!., 1973 ), indicating that the dog is less heterogene-
ous than man. 
The first reports on mixed lymphocyte reactions in dogs appeared in 1968 
(Serre and Clot), 1969 (Rudolph et a!.) and 1971 (Templeton and Thomas). 
Many different techniques have been used since (Gluckman, 1973; Grosse-Wilde 
et a!., 1973; van den Tweel eta!., 1974; M.L. Bach eta!., 1975; Goldman and Flad, 
1975). The outcome of the MLR in dogs appeared to be determined by the MHC 
analogous to the situation in other species. A recombination between the SD and 
MLR loci was reported which proved that the MLR is governed by a locus dis-
tinct from but closely situated to the SD loci (van den Tweel eta!., 1974). This 
locus has been labelled DLA-D (Joint Report of the Second International Work-
shop on Canine Immunogenetics, 1976). A strong linkage disequilibrium between 
SD and MLR loci was observed (van den Tweel eta!. 1974; Grasse-Wilde et al., 
1975b). Furthermore LD typing with homozygous reference cells appeared to be 
feasible in dogs. With the use of these typing cells a dog family was found in 
which two "LD types" segregated on one haplotype (Grasse-Wilde et a!., 
1975b). This suggested that the MLR in dogs is governed by more than one LD 
locus. 
Transplantation experiments with various organs clearly demonstrated the rel-
evance of matching for antigens of the canine MHC for graft prognosis (figure 
4 ). The differences in mean survival times for the different transplanted organs 
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are caused, among others, by organ specific differences (Vriesendorp et al., 1977b). 
The resemblance between the canine MHC and the human MHC justifies the use 
of the dog as a model for further transplantation research (Vriesendorp et al., 
1977a). The dog model is an excellent preclinical model not only for its immuno-
genetic characterizations, but also because outbred dogs are widely available. 
Even in a closed beagle colony out breeding can be effectuated, if the ancestor 
composition is sufficiently large (Rehfeld, 1970). 
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Figure 1.4. Effect of DLA matching on allograft survival in littermate donor-recipient pairs. 
a. One standard deviation of the mean is given. Each mean is computed from the survival 
times of at least 6 different animals, except for liver grafts, because only 2 animals have 
been grafted per group sofar. 
b. Recipients received 750 rads TBI and 100 mg silica/kg bodyweight i.v .. 
Reproduced, with permission, from: 
Genetics and transplantation immunology of the DLA complex. 
Vriesendorp, H.M., Bijnen, A.B., Westbroek, D.L. and van Bekkum, D.W. (1977) Transpl. 
Proc. 9, 293-296, Grune & Stratton Inc., New York. 
1.8. Objectives 
The goals of the transplantation immunological research in our laboratory are: 
a) to create and maintain a preclinical model which is optimally suited for trans-
plantation research, namely the dog, 
b) to assess the importance of histocompatibility matching for allograft survival 
in related and unrelated donor-recipient combinations, and 
c) to test various forms of treatment of recipients which may prevent or delay 
graft rejection in this model. 
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As a part of these objectives the studies presented in this thesis were initiated. 
At the time of the start of these studies the relevance of the MLR to graft surviv-
al in unrelated donor-recipient pairs was a main topic in histocompatibility re-
search. For an optimal interpretation of the test results for genetic studies and 
organ transplantation experiments it was felt essential to acquire an extensive 
insight into the kinetics of the MLR in various defined genetically different cell 
mixtures. These results will be described in chapter 3. 
For the selection of defined donor-recipient combinations it was thought to 
be useful to analyse the genetics of the MLR's which were primarily performed 
for transplantation experiments. Thls analysis is discussed in chapter 4. Further-
more it seemed essential to determine the importance of matching for MHC 
versus non-MHC gene products in renal allograft survival. Therefore, pairs of 
LD and/or SD identical beagles were selected. These animals were assumed to 
be identical for the other genes of the MHC as well. Kidneys were exchanged 
between these pairs and graft rejection was considered to be caused by differen-
ces for non-MHC antigens. As the number of non-MHC incompatibilities in these 
dogs had to be larger than in littermate donor-recipient combinations, the dif-
ferences in survival times between the DLA identical non.;;ibling and littermate 
donor-recipient combinations should be indicative of the importance of match-
ing for the MHC versus non-MHC antigens. These experiments are described 
in chapter 5. 
In chapter 6 the relevance of the subregions of the MHC for allografting is 
investigated. Therefore a number of kidneys was transplanted in donor-recip-
ient combinations of which donor or recipient was an MHC recombinant. Fur-
thermore, renal allografts were performed in unrelated donor-recipient combin-
ations which were typed for the known SD antigens of the MHC and tested in 
MLR. The latter experiment was performed to evaluate the relative importance 
of matching for MLR compared to matching for SD antigens for kidney graft 
survival. It was hoped that insight could be gained into the importance of the 
subregions of the MHC. These analyses are described in chapter 6. 
The order of the chapters does not reflect the chronological order of the ex-
periments. Some kinetical experiments were performed when an MLR result 
deviated from the expected pattern. The genetic studies were performed partly 
during donor-recipient selection programmes and the described recombinations 
were accidently discovered. Grafting of the recombinants was performed when 
they became available after more elaborate genetic studies. It was the purpose of 
the experiments described in this thesis to collect theoretical and practical in-
formation on the efficacy of histocompatibility matching for renal allografting 
in a well defined experimental animal, namely the tissue typed dog. 
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CHAPTER 2 
DESCRIPTION OF TECHNIQUES 
2.1. Serology 
For the experiments, described in this thesis, the one stage microlymphocyto-
toxicity test as described by Kissmeyer-Nielsen and Kierbye (1967) and adapted 
for canine lymphocytes by Vriesendorp (1973) was used. In this test, antiserum 
and complement are both added to the cells directly at the beginning of the in-
cubation period of 30 minutes at 37° C. Production and evaluation of the used 
test sera are described by Vriesendorp et al. (1971 ). With a battery of 70-90 of 
these tests sera the gene products of three linked loci can be recognized (Vriesen-
dorp, 1977b). Nomenclature decisions on the officially recognized specificities 
have been published in the Joint Report of the Second International Workshop on 
Canine Immunogenetics (1976). 
2.2. Mixed lymphocyte reaction 
2.2.1. Blood sampling 
Blood is drawn under sterile conditions by venipuncture from the forelegs or the 
external jugular vein and collected in a sterile siliconized glass bottle. Heparin 
(I ml of Thromboliquine (Organon, Oss, Holland) per 100 ml of blood) is used 
as anticoagulant. Defibrinated in stead of heparinized blood is sometimes used, 
when the cell suspensions are prepared on the day of blood sampling, to prevent 
clumping of cells. Defibrination is not done routinely, as inadvertent clotting 
may occur, extra manpower is needed to shake the bottles and the cell yield is 
considerably smaller compared to the cell yield with heparinized blood. 
2.2.2. Short term preservation of blood 
For logistical reasons blood sometimes is stored for one or two days at room 
temperature after dilution with at least an equal amount of culture medium 
(see § 2.2.5). 
Special care is taken that little or no air is left in the bottles and that they are 
closed air-tight. With this storage method cell viability remains over 90% (assess-
ed by the trypan-blue dye exclusion test) and no loss of reactivity in the mixed 
lymphocyte culture is noted. 
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2.2.3. Preparation of lymphocyte suspensions 
Handling of materials, media and blood components is performed, when possi-
ble, in a filtered air unit (obtained from REPGO-TNO, Rijswijk, the Nether-
lands). 
For the preparation of lymphocyte suspensions the following procedure is 
pursued: The blood/medium mixture is centrifuged in aliquots of 30 ml in sili-
conized 40 ml glass tubes for I 0 minutes at 900 g (1800 rotations per minute 
(= rpm) with the Heraeus UJ III E centrifuge). Then the plasma and buffycoat 
are collected and centrifuged during 10 minutes at 400 g (800 rpm), also in 40 
rnl glass tubes. The supernatant (with the bulk of the thrornbocytes) is removed 
down to 0.5 ern above the sediment and discarded. The cells are resuspended in 
medium RPMI-1640 (Flow, cat. no. 2-063M), underlayered with Ficoll-Isopaque 
(density 1.077 g/rnl) and centrifuged for 25 minutes at 900 g (1800 rpm) 
without breaking. The lymphocyte-rich interface is collected, quickly divided 
into two plastic Falcon tubes with 8 rnl of RPMI-1640 and centrifuged for 10 
minutes at 700 g (1400 rpm). This washing procedure is repeated twice. After 
the last turn the supernatant is removed completely. The cells are resuspended 
in I ml of culture medium for each I 0 ml of blood sampled, counted in a haerno-
cytometer (after dying with Tilrk) and readjusted to a final concentration of 
7.5 x 106 lymphocytes per mi. The yield is generally 1-2 x 106 lymphocytes 
per rnl of blood. The percentage of contaminating granulocytes is generally 
about 10%. 
2.2.4. Pretreatment of stimulator cells 
Irradiation from 1000 to 5000 rad completely prevents mitosis without inhibit-
ing the stimulating capacity of the cells (own observations). Therefore, a dose 
of 2500 rad (approximately 120 rad per minute, 250 KV) is chosen to abolish 
the mitotic potential of the stimulator cells. Pretreatment with mitomycin - C 
(A. Christiaens S.A., Brussels, Belgium) at 25 p gjml for 30 minutes is equally 
effective for preparing stimulator cells for dog lymphocyte cultures (van den 
Tweel et al., 1974 ). This method is more cumbersome and only used in our la-
boratory when irradation cannot be performed. 
2.2.5. Culturing 
Culturing is performed in a technique similar to the technique of Grossc-Wildc 
(1973). As a rule, each combination of cells is tested in quadruplicate. As a cul-
ture medium RPMI-1640 supplemented per 100 rnl with 10 rnMole freshly 
thawed I.-Glutamine (Gibco cat. no. 503 ), I ml of a solution containing 10,000 
I.U. penicillin and 10,000 p g streptomycin per rnl (Flow, cat.no. 7-0 I 0 C) and I 0 
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ml heat inactivated normal dog pool serum is used. The serum pool is prepared 
from 6 or more unimmunized sires and freshly frozen at - 70° C. Each serum-
pool is always tested in different concentrations in a control MLR and not kept 
for longer than one year. 
First, 0.2 ml of the culture medium is pi petted into the wells of a flat bottomed 
micro-titer plate (Falcon, cat. no. M 3040). Then 0.02 ml (containing 1.5 x 
105 cells) of the responder and stimulator cell suspensions each are added to 
each well with a tuberculin syringe and a specially adapted Hamilton dispenser 
(Hamilton Inc., cat. no. PB-600). The plates are covered with a sterile lid (Fal-
con, cat. no. M 3041) and incubated at 38° C in a slightly inclined position 
( 30°) in a water-saturated atmosphere containing 5% C02 . 
2. 2. 6_ Labelling 
Sixteen hours before harvesting radioactive labelled thymidine is added. Until 
march 1975, 2 If Ci of methyl-3H-thymidine (specific activity 5 Ci/mMole, 
Amersham, cat. no. TRA 120) was pipetted into each well; currently 0.8/fCi of 
methyl-3H-thymidine with a specific activity of 2 Ci/mMole (Amersham, cat. 
TRA 3 10) is used. 
2.2. 7. Harvesting 
Unless stated otherwise, harvesting is performed on the sixth day of culture. 
This is done by precipitating the cells from the cultures on glass fibre filters 
(Titertek, cat. no. 77-300-06) by means of a multiple sampling harvester (Ska-
tron, Lierbyen, Norway). 
2_2_8_ Counting 
The filters are dried and put in their correct order in disposable glass flasks with 
a plastic screwcap (Amphabel, cat. no. 430) and 2.5 ml of scintillation fluid (2.5 
liter Toluol, Merck, cat. no. 8325 supplemented with 0.025 g POPOP; Packard, 
cat. no. 6002030 and 15 g PPO, Merck, cat. no. 2946) is added. This amount is 
sufficient as the cells stay on the filter on the bottom of the vial. Scintillation 
counting is performed in a Packard Tricarb liquid scintillation spectrophotomet-
er (Model 3375) for one minute periods. The results are expressed as cpm 
(counts per minute) and recorded on a punch tape for computerized calculation 
of the means of the quadruplicates and the standard deviations. 
2.2. 9. Controls 
For a correct interpretation of the results appropriate negative and positive con-
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trois are essential. As negative control cultures a double dose of responder cells 
without stimulator cells, and a single dose with autologous stimulator cells are 
tested; the stimulator cells are tested in combination with allogeneic MHC differ-
ent stimulator cells. As positive controls all responder cells are cocultured with 
MHC different stimulator cells and vice versa. 
2.3. Renal allografting 
2.3.1. Donor nephrectomy 
The abdomen is opened through a midline incision. In the absence of anatomic 
abnormalities the left kidney is used. Artery and vein of the donor kidney are 
dissected free close to the aorta and vena cava and the ureter is transected close 
to the bladder. Immediately after removal most kidneys were perfused with 50-
100 ml cold (4'C) Isodex, Organon, Oss (supplemented with 5.106 I.U. penicillin 
and 20 m1 lidocaine 2% per 500 ml), followed by a simultaneous perfusion of invert 
sugar l 0% and NaHC0 3 1.4%. In later series the kidneys were perfused with NaCl 
0.9% (supplemented with 25 mg heparine, Thromboliquine, Organon, Oss and 50 
ml procaine 2% per 500 ml). 
2.3.2. Renal implantation 
The donor kidney is implanted via a midline incision into the contralateral 
(usually right) iliac fossa of the recipient. First the renal vein is anastomosed 
end to side to the common iliac vein while the cold perfusion is continued. 
Thereafter the renal artery is anastomosed end tot end to the external iliac art-
ery. If the donor kidney has two arteries, a second end to end anastomosis is 
made with the caudal artery. The ureter is anastomosed to the bladder through 
a submucosal tunnel. Finally a bilateral nephrectomy of the recipients own 
kidneys is performed. 
2.3.3. Postoperative care 
Penicillin (l million l.U.) and streptomycin (l g) daily is started at the time of 
the operation and continued for 5 days. Parenteral fluids (subcutaneous NaCl 
0.9% and glucose 5%, or mixed infusions) are administered during the first two 
postoperative days. Thereafter a standard diet is given (Hope Farm). No immu-
nosuppression is given and no special supportive measures are taken when rejec-
tion starts. 
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2.3.4. Determination of graft survival 
Transplant function is assessed by regular estimations of the serum creatinine 
and urea. The postoperative day on which the animal died from renal insuffic-
iency or on which the serum creatinine rose above 1000 l"mole/1 is taken as the 
end point of graft survival. The animals which remain alive with a creatinine 
above 1000 I" mole/! are killed with an overdose of pentothal. An autopsy and 
histological examination of the graft are always performed to check the diagno-
sis "immunological rejection". 
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Chapter 3 has been submitted for publication 
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CHAPTER 3 
VALUE OF THE MIXED LYMPHOCYTE REACTION 
IN DOGS AS A GENETIC ASSAY 
A.B. Bijnen 1 , A.M. Dekkers-Bijma1, H.M. Vriesendorp2 and D.L. Westbroek 1 
1 Laboratory for Experimental Surgery, Erasmus University, Rotterdam, 
The Netherlands 
2 Radiobiological institute GO, TNO, Rijswijk, The Netherlands 
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Summary 
For an optimal use of the mixed lymphocyte reaction (MLR) for genetical and 
transplantation research in dogs, insight into the kinetics of the test is required. 
Therefore, cell-dose response curves have been performed in various defined gen-
etically different cell mixtures. The optimal cell dose was variable. No relation 
between genetic disparity and optimal cell doses or responder/stimulator cell 
ratios was found. In time-<:ourse kinetic studies earlier peak reactivity was ob-
served with combinations of unrelated than of related dogs. No difference was 
found comparing one ·with two haplotype different related dogs. These results 
can be explained by the assumption that in those combinations which differ for 
the major histocompatibility complex (MHC), non-MHC gene products can 
influence the outcome of the MLR. 
For a semi-quantitative evaluation a shorter culture period is preferred than 
that used for the determination of MLR negativity. Apparently the combined 
use of different modifications of the test procedure for a single cell combin-
ation may increase the power of the test as a genetic tool. It remains to be seen 
whether such modifications will be sufficient for a complete evaluation of the 
complex genetic control of the MLR and its relevance to homotransplantation. 
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Introduction 
The major histocompatibility complex (MHC) is a chromosomal region, contain-
ing many different genes. Matching for antigens of the MHC in related donor-
recipient pairs generally results in matching for whole MHC haplotypes and is an 
effective means to improve kidney allograft survival in such donor-recipient com-
binations (Singal et al., 1969; Brynger et al., 1977; Opelz and Terasaki et al., 
1977). Matching for the whole MHC in unrelated donor-recipient pairs is practic-
ally impossible due the polymorphism of the genes which can be identified in 
the MHC and the far larger number of genes which cannot yet be identified. 
At present it is unknown which loci of the MHC are most important for graft 
survival. Studies in mice have shown that some subregions of the MHC do con-
tain transplantation genes, while others do not (Klein, 1975). Several clinical 
studies indicate that the outcome of the mixed lymphocyte reaction (MLR) is 
an important prognostic parameter for kidney allograft survival (Cochrum et al., 
1973; Festenstein et al., 1976; Opelz and Terasaki, 1977). 
For a precise determination of the importance of compatibility for MLR for 
homotransplant survival a detailed insight into the kinetics and the genetic 
control of the MLR is required. The dog appears to be a good animal model 
because of the knowledge which has been obtained in the past of it's MHC. The 
variety of possible immunogenetic different donor-recipient combinations en-
countered in man, is also encountered in the dog (Vriesendorp et al., 1977). 
Previously, evidence has been reported which indicates that more than one 
pair of loci is involved in the genetic control of the MLR in the dog (Bijnen et 
al., 1977). In this report the applicability of the MLR as a genetic test is studied. 
Therefore the kinetics of the MLR and the correlation between the kinetics of 
the MLR and the genetic disparity between responder and stimulator cells has 
been investigated. 
Material and methods 
Mixed lymphocyte reactions 
Blood was sampled from non-immunized dogs only. Lymphocyte preparation 
and incubation of cell mixtures was performed as previously described (Grasse-
Wilde et al., 1973; Bijnen et al., 1977). In short, lymphocyte suspensions were 
prepared from heparinized blood on a FicolHsopaque gradient. Each cell com-
bination was tested in quadruplicate with the appropriate controls in microliter 
plates. Stimulator cells were irradiated with 2500 rad. Culturing was done in 
medium RPMI-1640 at 38°C in a water-saturated atmosphere, containing 5% 
C02. Harvesting was done after a 16 hour period of labelling with tritiated 
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thymidine. The results are expressed in counts per minute as the mean of the 
quadruplicates. 
Cell-dose response curves were obtained by varying the number of responder 
cells, keeping the number of stimulator cells constant (150,000 cells per well), 
by varying the number of stimulator cells, while keeping the number of respon-
der cells constant (150,000 cells per well), and finally by varying the responder/ 
stimulator cell ratio keeping the total number of cells constant (300,000 cells 
per well). 
Time-course kinetics were studied by harvesting on days 5, 6, 7 and 8 of cui-
30 60 
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Figure 3.1. Optimal number of responder cells per well in MLR. The number of stimulator cells was 
150,000 per welL Means ± standard error of the mean (s.c.m.) are given. All autologous 
controls were below 2,000 counts per minute (cpm). 
o one haplotype difference 
o two haplotypcs difference 
The experiments of figures 1,2,3,5 and 6 could not be repeated with the same 
cells for logistical reasons. However, similar curves were obtained in various 
other experiments with different cells of the same genetic combinations, except 
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for the stimulator cell-dose response curves (figure 2), of which only a small 
number of experiments was performed. 
DLA typing 
Typing for the DLA antigens (i.e. antigens of the MHC of the dog) was done by 
serological methods (the so called serologically defined or SD antigens) and 
lymphocyte cultures (the lymphocyte defined or LD antigens). DLA-SD typing 
was performed using techniques and antisera which were described previously 
(Vriesendorp et al., 1973; Vriesendorp et al., 1977). For DLA-LD typing the 
following homozygous reference cells were available during this study: DLA-50, 
DLA-51, DLA-52, DLA-53, DLA-54, DLA-55, DLA-56, DLA-57, DLA-58, Rl and 
R2. DLA and a number refer to the nomenclature recommendations which are 
given in the Joint Report of the Second Workshop on Canine Immunogenetics in 
Portland (1975). Rl and R2 refer to presently only locally (Rotterdam) recog-
nized LD types, which await a more official designation after international 
comparison. 
Cells from four genetically different combinations were analyzed in cell-dose 
response curves and time-course kinetics, namely DLA identical sibs, DLA one 
haplotype different sibs, DLA two haplotypes different sibs and DLA two ha-
plotypes different unrelated dogs. Mongrels as well as beagles were used. DLA 
identity always included SD as well as LD identity; DLA differences were always 
for SD as well as for LD determinants. 
Results 
Cell dose response curves 
Figure 1 shows the responder cell-dose response curve of a one and a two haplo-
type different combination on day 5 and day 6 of culture. The number of 
stimulator cells was fixed at 150,000 cells per well. The response appears to be 
proportional to the cell- dose up to a dose which is between 150,000 and 
300,000 responder cells per well. The minimal responder cell dose which is 
required to obtain a positive result is between 30,000 and 60,000 cells per well. 
In some other tests this threshold cell-dose was even I 00,000 cells per well. In 
this figure a maximal response is seen using 180,000 - 300,000 cells per well. 
With still higher responder cell-doses, a decrease of the response is noted. 
More of such cell-dose response curves have been performed in different 
genetic combinations. Four different combinations of DLA identical siblings 
were tested with cell-doses up to 600,000 cells per well. The response was 
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always negative with any of the tested responder cell-doses. Furthermore, one 
haplotype different siblings, two haplotype different siblings and two haplotype 
different unrelated individuals have been tested. Table I shows that the optimal 
responder cell number is mostly equal in one and two haplotype different com-
binations. No differences are noted between the optimal responder cell-doses of 
unrelated compared to related individuals either. 
Table 3.1. Optimal responder cell-dose and genetic disparity in MLR3 . No obvious influence of MHC or 
non-MHC differences on the optimal responder cell-dose is observed. 
responder 
I 
2 
3 
4 
5 
6 
7 
genetic relation between responder and stimulator 
related 
1 haplotype 
different 
1.2 X JQ5; 1.8 X JQS 
3.0x JQS 
3.0x JQ5 
l.SxJQ5 
3.0x JQS 
3.0x JQ5 
3.0 X JQ5; 4.0 X JQ5 
related 
2 haplotypes 
different 
I.8xJ05 
4.0x JQ5 
3.0x JQ5 
1.5 X JQ5; 1.5 X JQ5 
3.0xJQ5 
] .8 X JQ5 
unrelated 
2 haplotypes 
different 
5.0xJ05 
4.0 X JQS 
I.Sx 105 
1.5 X JQS 
3.0xJ05 
a Seven responder cells were tested in MLR with stimulator cells from one and two haplotypes different 
related and two haplotypes different unrelated cell donors. Harvesting was performed on the 5th day of 
culture. 150,000 stimulator cells were used per well. For responder cells I, 3 and 7, cell-doses of I, 2, 3, 4, 
5 and 6 x I as cells per well were tested. For responder cells 2, 4, 5 and 6, cell-doses of 0.3, 0.6, 0.9, 1.2, 1.5, 
1.8, 3.0 and 6.0 x I ()5 cells per well were tested. 
A comparison within one experiment can be made for the observed optimal responder cell-dose between 
the various genetic different culture combinations. The optimal responder cell-dose can be considered 
higher for the two haplotypes different (compared to the one haplotype different) related culture com-
binations in 2 instances (responder cells 1 and 2); equal in 3 instances (responder cells 3, 4 and 5) and lower 
in one instance (responder cell 6). Similarly the optimal responder cell-dose can be considered higher for 
unrelated (compared to related) culture combinations in 2 instances (responder cells 2 and 3), and lower 
in 3 instances (responder cells 5, 6 and 7). Thus, no obvious difference in optimal cell-dose between the 
various genetic groups is found. 
Figure 2 shows a stimulator cell-dose response curve on day 5 and day 7 of cul-
ture. The number of responder cells was fixed at 150,000 cells per well. As with 
the responder cell-dose response curve, an optimal cell-dose can be seen. A posi-
tive reaction is seen with as few as 30,000 stimulator cells per well. In some other 
tests at least 60,000 stimulator cells per well were required to obtain a positive 
reaction. It is remarkable that with a culture period of 7 days the curves of the 
one and the two haplotypes different combinations in the figure cross each 
other. This test was performed only once; however it indicates that at a culture 
length of 7 days and 150,000 responder cells and 150,000 stimulator cells no 
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reliable quantitative interpretation can be made. At day 7 in this test, quantitat-
ive discrimination can only be made when 60,000 stimulator cells per well are 
used. 
40 day 7 
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Figure 3.2. Optimal number of stimulator cells per well in MLR. The number of responder cells was 
150,000 per welL Means ± s.e.m. are given. All autologous controls were below 2,000 cpm. 
eone haplotype difference 
otwo haplotypes difference 
Only a small number of stimulator cell-dose response curves was performed; 
therefore no conclusion can be drawn on the presence or absence of differences 
between the various genetic groups. 
Figure 3 is an example of an experiment in which the influence of the respon-
der/stimulator cell ratio was investigated, keeping the total number of cells 
constant (300,000 cells per well). The optimal responder/stimulator cell ratio 
appears to be variable. In 5 out of 12 experiments, peak reactivity was found 
at a 1/1 ratio. No obvious differences between the different genetic groups 
were noted. Negative reactions however were noted in 2 and 4 out of 12 mix-
tures when 2/1 and 5/1 .-esponder/stimulator cell ratios were used respectively. 
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Thus, with responder/stimulator cell ratios above 1, false negative results may 
be obtained. 
cpm x IQ-3 
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Figure 3.3. Optimal responder (Rs): stimulator (Sm) cell ratios in MLR. The total number of responder 
+stimulator cells was 300,000 per well. Means ± s.e.m. are given. All autologous controls 
were below 2,000 cpm. 
Time - course kine tics 
To determine the optimal day of harvest for a semiquantitative evaluation of the 
MLR, thirty different MLR mixtures have been harvested each on three different 
days of culture on two different occasions several weeks apart. Both experiments 
were performed with fresh cells. 150,000 responder cells and 150,000 stimulator 
cells per well were used. The results are presented in figure 4. The best correl-
ation between the level of stimulation in the first and the second experiment was 
found when harvesting was performed on the 5th day of culture (figure 4•, r = 
0.78); the worst correlation was found when the mixtures were harvested on the 
7th day of culture (figure 4C, r = 0.44). Another experiment has been perform-
ed with similar results. 
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Furthermore, optimal stimulation may be obtained at different days of cul-
ture in different cell combinations. An example is shown in figure 5. Here, one 
responder cell reacts to different stimulator cells in one experiment. The peak 
reactivity of this responder cell is on day 5 (or maybe earlier), day 6 or day 7, 
depending on the stimulator cell used. Thus, the better test reproducibility on 
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Experiment I 
Figure 3.4. Optimal culture length and reproducibility of MLR. Thirty MHC different cell mixtures have 
been harvested each on day 5 (figure 43), day 6 (figure 4b) and day 7 (figure 4C) of culture. 
The two combined experiments I and II were each performed with fresh cells with an interval 
of several weeks. The correlation coefficients were 0.78, 0.71 and 0.44 at day 5, 6 and 7 of 
culture respectively (Spearman test). Only the means of the quadruplicates are given. All 
autologous controls were below 2,000 cpm. 
(e) means: cpm <1,000 
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day 5 of culture and the differences in time-course kinetics both imply that 
early (day 5) harvesting is essential when a semi-quantitative evaluation of the 
MLR is needed. In some tests however peak reactivity was seen on day 8 or 
cpm x w-3 
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Figure 3.5. Optimal harvest day in_ MLR. 150,000 responder cells and 150,000 stimulator cells per well 
were used. Means ± s.e.m. are given. All autologous controls were below 1.000 cpm. These 
curves were obtained by testing one responder cell against three different stimulator cells in 
one experiment. 
later, while no significant reactivity was seen on day 5. Therefore it appears 
advisable for the establishment of MLR negativity to harvest on a later day 
than the 5th day of culture. 
Time-course kinetics have also been performed with different responder/sti-
mulator cell ratios. An example is shown in figure 6. It appears that the day of 
peak reactivity here is independent of the cell ratios used. Thus it is unlikely that 
exhaustion of the culture medium is an important cause for the observed decline 
in reactivity after a certain number of days in culture. The results suggest rather 
that the day of peak reactivity is dependent on the tested cell combinations. 
Possibly, genetic factors play a role. Therefore, time-course kinetics have been 
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performed in different combinations. Table 2 presents the results. It appears that 
peak reactivity is more variable and generally earlier in the unrelated compared 
to the related MLR combinations (X2 = 7 .18, P < 0.05). No difference in peak 
cpm x lQ-3 
Rs Sm 
100 
50 
5 6 7 8 
day of harvest 
Figure 3.6. Optimal responder (Rs): stimulator (Sm) ratio and harvest day in MLR. The total number of 
responder +stimulator cells was 300,000 per well. Means ± s.e.m. are given. All autologous 
controls were below 2,000 cpm. The curves were obtained by testing one responder - stimula-
tor cell combination in different ratios in one experiment. 
day has been observed between one and two haplotype different related combin-
ations. These observations suggest that non-MHC genes influence the outcome 
of the MLR. However, no stimulation has been seen at any length of culture in 
six DLA identical sibling combinations. Apparently, the role ofnon-MHC genes 
can probably only be appreciated in MHC different combinations. 
Discussion 
The kinetics of the MLR in dogs have been described before by Goldmann and 
Flad (1975) for a semi-micromethod in small test tubes. The present results in 
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Table 3.2. Optimal culture length in days and genetic disparity in MLRa. No obvious influence of MHC 
differences on the optimal culture length is observed, but non-MHC differences may accelerate 
(or delay) the response 
genetic relation between responder and stimulator 
related related unrelated 
I haplotype 2 haplotypes 2 haplotypes 
responder different different different 
6:6 6 5 
2 6 ;6 6 5 
3 7 7 6 
4 6 ;6 ;6: 7 5 
5 8;8 6 : 7 
6 6 ;6 :6 ;6 6 
7 7 7 7 
8 6 ;6 6;6 
9 6 6 ;7 ;7 
10 6 7 
a Ten responder cells were tested in MLR with stimulator cells from one and two haplotypes different 
related and two haplotypes different unrelated cell donors. Harvesting was perfonned on the 5th, 6th, 7th 
and sth day of culture. 150,000 responder cells and 150,000 stimulator cells per well were used. The 
optimal culture days are given. 
A comparison of the optimal culture length in days within one experiment can be made between the 
various genetic different culture combinations. No difference in culture length was observed between the 
5 one and two haplotype different related culture combinations tested (responder cells I, 2, 3, 7 and 8). 
The optimal culture length in two haplotypes different unrelated culture combinations was shorter compar-
ed to two haplotypes related culture combinations in 3 instances (responder cells I, 2 and 3) and compared 
to one haplotype different related culture combinations in 2 instances (responder cells 4 and 5); equal to a 
one and a two haplotypes different combination each in 1 instance (responder cells 6 and 7 respectively); 
and longer compared to two haplotypes different culture combinations in 2 instances (responder cells 9 
and 10). Thus, the optimal culture length appears to be more variable (and mostly shorter) in unrelated 
compared to related culture combinations. 
microliter plates confirm and extend their results. It appears that relatively high 
numbers of responder and stimulator cells (over 100,000 per well each) in a ratio 
of 1/1 can safely be used in order to determine whether an MLR between two 
individuals is positive or negative. This means that the procedure routinely used 
in our laboratory (150,000 responder cells and 150,000 stimulator cells, harvest 
on the 6th day of culture) is applicable for a determination of MLR negativity 
and MLR positivity. However, no quantitative conclusions can be drawn. For a 
semi-quantitative comparison of the reactivity of one responder cell against 
several different stimulator cells in the same experiment, it would appear better 
to use lower numbers of responder and stimulator cells (e.g. 100,000 cells per 
well each) and to harvest earlier (day 4 or 5). With such a procedure false negat-
ive results may be obtained more often, but quantitative differences can be 
measured which would be obscured when testing occurred beyond the peak 
of the MLR reactivity curve. 
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Important prerequisites for a test which is used to assign LD determinants 
to individuals, are that Mendelian inheritance of the determinants can be shown 
and that their segregation in a family should predict for negative and positive 
MLR's within that family. This is usually the case (Bijnen et al., 1977 -Chapter 
4; Vriesendorp et al., 1977). However an exception to this rule has been des-
cribed (Bijnen et al., 1977 - Chapter 4 ). In contrast, if two unrelated dogs have 
two different LD determinants in common, the MLR is often positive (Bijnen 
et al., 1977 - Chapter 4 ). The described discrepancies between LD typing and 
the outcome of the direct MLR may be explained by assuming more than one 
locus for MLR. An alternative explanation is that with the LD typing cells 
used, not only LD identical individuals are selected, but also individuals with 
slightly different but "cross-reacting" LD antigens. In this report evidence has 
been obtained which suggests that differences for non-MHC genes can amplify 
the effect of differences for MHC genes. If this hypothesis were to prove true, 
then it would mean that small MHC differences may sometimes result in a 
strongly positive MLR, obscuring MHC similarity. Thus positive and, in partic-
ular, weakly positive MLR reactions (as the so called "typing responses") in 
man (Keuning et al., 1975) might be indicative of differences between stimu-
lator and responder cells for MHC gene products as well as for non-MHC gene 
products. 
Clearly a better insight into the genetic control of the MLR is required for a 
more exact evaluation of the genetics and histocompatibility effect of the indi-
vidual LD loci. A further combined use of different modifications of the MLR 
for each test combination in new family and population studies will show 
whether such modifications sufficiently increase the power of the MLR as a 
genetic tool. If they do not allow an adequate discrimination between MHC and 
non-MHC influences on MLR reactivity, other methods may be required for the 
determination of LD gene products. 
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CHAPTER4 
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Summary 
The genetics of the MLR of the dog are studied using LD typing cells. The four 
new homozygous reference cells described bring the total number of defined LD 
specificities in this species to ll. In families, LD specificities generally segregate 
en bloc with the SD specificities of the DLA complex. The recombination fre-
quency between the SD and LD loci is provisionally estimated to be 0.007. A 
slight but significant stimulation between two SD identical LD typed siblings 
could not be explained on the basis of a single recombination between the SD 
loci and one LD locus and therefore suggested the existence of an additional 
LD system. 
Unrelated SD different individuals with two different LD determinants in 
common frequently stimulate each other in MLR, but low responses are also 
encountered. The results described are compatible with a hypothesis of two seg-
regant series of alleles for the genetic control of the MLR and linkage disequi-
librium between certain alleles of these series. More conclusive evidence of the val-
idity of this hypothesis and further knowledge of other factors which determine 
the response in the MLR are required before a reliable estimate of the importan-
ce of LD structures in histocompatibility can be made. 
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Introduction 
Histocompatibility studies in the dog have shown that, as in other species, one 
Major Histocompatibility Complex (MHC) exists, which is located on an auto-
somal chromosome (Vriesendorp et al. 1971, Templeton & Thomas 1971, Joint 
Report of the First International Workshop on Canine Immunogenetics 1973, 
Joint Report of the Second International Workshop on Canine Immunogenetics, 
1976). 
The genetic control of lymphocyte defined (LD) antigens which determine 
the outcome of Mixed Lymphocyte Reactions (MLR) was found to be closely 
linked to, but distinct from, the genetic control of serologically defined (SD) 
antigens (van den Tweel et al. 1974, Grosse-Wilde et al. 1974). Typing for LD 
determinants in dogs (Grosse-Wilde et al. 1975, Goldmann et al. 1975) can be 
performed following the same principles as in man (Mempel et al. 1973, Keuning 
et al., l97Sa), i.e. by using LD homozygous cells as stimulators in MLR. For a de-
termination of the relevance of LD typing to histocompatibility in unrelated 
donor-recipient pairs, detailed information on the genetic control of the MLR 
is required. 
Although, in the past, the majority of canine MLR results have been explain-
ed by assuming the presence of one locus only for MLR, evidence has been ob-
tained indicating that more loci might be involved (Grosse-Wilde et al.l975b). In 
this report new family and population studies are presented which are most ef-
ficiently explained by a polygenic control of MLR in the dog. 
Material and Methods 
Dogs 
Blood samples were taken from beagles, labradors and mongrel dogs of the colo-
nies of Het Centraal Proefdierenbedrijf TNO, Austerlitz, the Netherlands (Dr. J. 
van Vliet) and of the Erasmus University, Rotterdam (Dr. W. van Dijk). 
Serology 
A battery of 70-90 different alloantisera was used in a one-stage microcytotoxi-
city test to type for the serologically defined antigens as described before (Vrie-
sendorp 197 3, Smid -Mercx et al. 197 5 ). 
Mixed lymphocyte reactions 
Unilateral cultures were performed in a micromethod as described previously for 
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the dog (Grasse-Wilde et a!. 1973). In brief, lymphocyte susoensions were pre-
pared from heparinized blood by centrifugation on a Ficoll-lsopaque gradient. 
Each cell combination was tested fourfold with the appropriate controls in tilted 
flat bottom micro titer plates, using 150,000 responder cells and 150,000 stimu-
lator cells per well. Stimulator cell suspensions were irradiated with 2500 rad. 
Culturing was done in RPMI-1640 at 38°C in a water-saturated atmosphere, con-
taining 5% C0
2
• Harvesting was performed on the sixth day of culture after a 
16-h period oflabelling with tritium-labelled thymidine. The results are expressed 
as the mean of the quadruplicates, or as a relative response (R.R.), i.e. the per-
centage of the median of the three highest responses of a given cell. 
Other markers 
Polymorphic red and white cell enzymes (Meera Khan eta!. 1973) and canine 
secretory alloantigens (Zweibaum et a!. 1974) were tested to check the reliabil-
ity of the recorded paternity. 
Nomenclature 
The new recommendations for the nomenclature of the loci within the MHC in 
the dog are used (Joint Report of the Second International Workshop on Canine 
Immunogenetics 1976). In analogy with the situation in man, the SD loci have 
been labelled DLA-A and DLA-B. A third SD locus, which has recently been re-
cognized (Vriesendorp et a!. 1977) and provisionally has been designated 
DLA-C, is not included in this analysis. 
The LD systems will remain unlabelled until more data are available on the 
number of LD loci within the DLA complex and the assignment of currently 
known LD specificities to these loci. 
Results 
LD typing cells 
At present II different homozygous reference cells are available (Table I). They 
all stimulate each other in MLR and hence represent different specificities. For 
technical reasons the specificity R2, associated with DLA-A7-B- in the beagle 
was not tested with DLA-54. As the specificity DLA-54 was not present in 
eight beagles carrying the haplotype DLA-A7-B- (Grosse-Wilde et a!., !97Sb), 
R2 and DLA-54 probably represent different LD types. The old specificities 
DLA-50, DLA-51, DLA-52, DLA-53, DLA-54, DLA-55 and DLA-56 have 
been described before (Grosse-Wilde et a!., 197Sb). The new specificities have 
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Table 4. I. MLR results expressed in cpm x 10-3 of 11 LD homozygous typing cells 
Dog 
4.440 
02.179 
04.583 
B 270 
017 
066 
L 16 
37 wx 
4.334 
T 46 
05.314 
LD 
type 
50 
51 
52 
53 
54 
55 
56 
57 
58 
Rl 
R2 
SD 
type 
A2 -B4 I A2-B4 
A2 -B5 /A2-B5 
A9 -B6 /A9-B6 
A3 -B-/A3-B-
AIO-B5 /A7-B-
A3 -B-/A3-B-
Al -B13/AI-B13 
AS -BI3/A8-B13 
A9 -B4 /A9-B4 
A7 -B13/A7-Bl3 
A7 -B-/A7-B-
sox 
0 
27 
42 
12 
6 
28 
38 
18 
24 
16 
30 
Six 
50 
0 
46 
27 
7 
59 
50 
28 
39 
14 
67 
52x 
57 
74 
0 
48 
8 
46 
44 
22 
58 
13 
NTa 
a NT • not tested. Difference of LO type is known from earlier experiments 
53x 
NT' 
NT' 
N'P 
0 
NT' 
23 
41 
19 
60 
15 
65 
54x 
7 
8 
12 
6 
0 
10 
8 
16 
17 
17 
NT' 
ssx 
72 
73 
55 
38 
13 
0 
41 
20 
64 
20 
75 
56x 
59 
59 
47 
43 
13 
52 
2 
20 
21 
20 
43 
Table 4.2. MLR results of a dog family (expressed as a relative response) favoring the existence of two loci for LD 
Father 
Mother 
Sib I 
Sib 2 
Sib 3 
Sib 4 
Sib 5 
Sib 6 
SD genotype 
A9-B6/A9-B4 
A2-B4/AI-B13 
A9-B6/ A2-B4 
A9-B6/A2·B4 
A9-B6/A2-B4 
A9-B6/AI-B13 
A9-B6/AI-B13 
A9-B6/AI-B13 
Fx 
2 
89 
81 
66 
67 
45 
75 
61 
Mx 
56 
8 
45 
60 
67 
33 
92 
56 
IX 
84 
78 
2 
2 
59 
51 
108 
89 
2x 
56 
98 
7 
133 
109 
100 
117 
3x 
64 
67 
63 
78 
2 
73 
100 
100 
4x 
164 
100 
151 
107 
100 
14 
5x 
100 
78 
100 
82 
89 
16 
6x 
100 
83 
89 
96 
93 
18 
15 
2 
sox 
88 
l§ 
• !.Q 
11 
70 
55 
82 
57x 
26 
21 
24 
23 
6 
24 
23 
0 
43 
9 
38 
52x 
1 
78 
l 
1 
85 
1 
1 
1 
58x 
48 
24 
34 
33 
10 
31 
44 
18 
0 
32 
46 
56x 
80 
!i 
72 
100 
70 
l 
1 
3.! 
Rlx 
29 
39 
30 
20 
29 
22 
13 
9 
22 
0 
29 
R2x 
14 
37 
20 
9 
NT' 
61 
56 
25 
32 
16 
0 
58x R.R.=IOO% 
cpm x 10-3 
a 
100 
96 
93 
l 
100 
100 
83 
25 
18 
57 
28 
27 
33 
30 
36 
provisionally been labelled DLA-57 (Munich), DLA-58 (Rotterdam), Rl (Rot-
terdam) and R2 (Rotterdam). The homozygosity of all typing cells has been 
been verified by a one-way non-stimulation with both parental cells with the ex-
ception of DLA-5 5 which was only non-stimulatory to paternal cells. 
LD-SD inheritance in dog families 
Forty-nine members of six different beagle families were tested in a family MLR 
together with the relevant typing cells. In none of the families was false patern-
ity observed. As a rule, an LD determinant segregated en bloc with a particular 
SD haplotype. In all families LD typing of the offspring predicted the outcome 
of the MLR performed between sibs. Thus sibs with two LD specificities in com-
mon did not stimulate each other in MLR, while the MLR in combinations with 
different LD specificities was positive. In one family two exceptions were obser-
ved (Table 2). In six individuals the SD haplotype A9-B6 of the father was asso-
ciated with the LD determinant DLA-52. Sib 3 inherited the SD haplotype A9-
B6 together with the paternal LD determinant DLA-58. Thus a recombination 
between SD and LD must have occurred. This is consistent with the results of 
the family MLR, as sib 3 is positive in MLR with its SD identical sibs 1 and 2. 
Sib 6 differed slightly in MLR from her SD identical sisters 4 and 5. This ob-
servation cannot be explained by assuming a simple recombination between SD 
and LD, as she strongly differs in MLR from her brothers 1 and 2. The LD typ-
ing results are consistent, as she reacts slightly to the homozygous typing cell 
DLA-56. 
Repeated MLR testing and SD typing confirmed the results in this family. 
Recombination frequency 
In our total family material, 241 haplotypes were informative for a recombina-
tion between SD and LD. In one haplotype, a recombination was observed. If 
these data are combined with earlier obtained family MLR data (van den Tweel 
et al. 1974) the recombination frequency between the SD and the major LD 
locus in the dog can be estimated to be 2:307 = 0.007 (5% confidence limits 
0.001-0.024 ). 
LD typing in unrelated individuals 
In Fig. 1, the MLR results of 46 SD different heterozygous unrelated cell com-
binations (mongrel-mongrel and beagle-mongrel) with two LD specificities in 
common (as defined by previous LD typing by Grosse-Wilde et al. 1975°) arc 
shown. It can be concluded that the MLR is frequently positive. A low response 
(R.R. below 30%) is observed in 26% of the tested combinations. The R.R. in 
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this group is significantly lower than the R.R. in 50 SD different LD different 
combinations (P < 0.00 I, Wilcoxons rank sum test). 
The level of the R.R. was not related to the LD specificities in common. No 
apparent correlation was observed between a higher R.R. and the presence of dif-
ferences for antigens of the DLA-A and/or DLA-B series in this limited material. 
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Figure 4.1. Relative responses in 46 SD different combinations with two LD determinants in common 
("LD typing identical") and 50 SD different LD different combinations. 
Discussion 
Negative MLR's are rare between random unrelated individuals. This limits the 
evaluation of the influence of a negative MLR on graft survival. Typing for LD 
may be a tool to select donor-recipient pairs that will not stimulate each other 
in MLR. The four new canine LD homozygous reference cells described here 
bring the number of different defined LD specificities in this species to ll. An 
estimate of the remaining, still undefined LD alleles cannot be made until the 
number of different LD loci is known. 
The reported results of LD typing in dog families demonstrate that LD spe-
cificities are genetically determined characteristics which segregate en bloc with 
the SD specificities of the DLA complex. The observation that sibs which are 
identical for two independent LD specificities never stimulate each other in 
MLR, while sibs, which differ for one or two LD specificities, always do, even in 
the event of a recombination between the SD and LD loci (Table 2), strongly 
suggests that by LD typing, one types for structures that determine the outcome 
of the MLR. 
The recombination frequency between the SD and LD loci of 0.007 in the 
dog is similar to the recombination frequency in man (0.007, Keuning et 
57 
a!. 1975b; 0.009, Netzel et a!. 1975). These calculations are based on the as-
sumption that only one major MLR locus exists. A more accurate figure cannot 
be given before the number and relative positions of the SD and LD loci are 
known. 
2 
II 
52-A9-B6/o 52-A9-B6/o 
50-A2-B4/Y 50-A2-B4/Y 
52-A9-B6/a 
58-A9-B4/' 
3 
50-A2-B4/Y 
2 
50-A2-B4/Y 
56-Al-813/0 
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56-AI-Bl3/Y 
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52-A9-B6/a 52-A9-B6/a 
56-Al-813/5 56-Al-813/Y 
------.-
Figure 4.2. Proposed genotypes in an SD-LD recombination family. Genes of an additional LD locus are 
represented by Greek characters. 
The occurrence of a weak but significant stimulation between sib 6 and its SD 
identical sibs 4 and 5 of table 2 coincides with a low but significant response 
to the typing cell DLA-56. This can be explained by a polygenic control of the 
MLR. The proposed genotypes of this family are depicted in Fig. 2. The deter-
minants of the new LD locus are symbolized by Greek characters. They may be 
identical in the father, but not in the mother. This new LD locus may or may 
not be situated on the same chromosome carrying the DLA complex, but should 
be located outside DLA-A and B. 
The results in this dog family are very similar to the human family described 
by Suciu-Foca & Dausset (1975). Less obvious explanations for the observations 
in this family are the possibility of a mutation in an LD gene or a double recom-
bination in the MHC region of one chromosome. 
From earlier studies in the dog it is known that a high linkage disequilibrium 
exists between certain alleles of the SD and LD loci (van den Tweel eta!. 1974). 
Therefore, a negative MLR is frequently found between SD identical individuals, 
but rarely between SD different dogs. From the results with typing cells in fami-
lies one might expect that the MLR between SD different unrelated dogs with 
two LD determinants in common is negative. However, it now appears that the 
MLR is frequently positive. This observation favors the hypothesis that more 
than one LD locus exists. On the other hand, the finding that in 26% the R.R. is 
below 30% indicates that with incomplete LD typing, identity may occur due to 
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the presence of linkage disequilibrium between LD alleles of different series. This 
situation is similar to the situation in man, where a positive MLR was also fre-
quently found between persons identical for two LD specificities (Grasse-Wilde 
et al., 1975a). 
A considerable number of observations is now available which argue against 
the genetic control of the MLR in the dog by only one locus, i.e.: 
a) the occurrence of more than one LD determinant in a typing cell and a haplo-
type (Grasse-Wilde et al., 1975b). 
b) a positive reaction between SD identical LD typed siblings, which cannot be 
explained by a single recombination between the SD loci and only one LD 
locus (this report). 
c) a slightly positive reaction in MLR of some individuals of a family with only 
one out of several mutually negative homozygous cells of the same family 
(Goldmann et al., 197 5). 
d) a high frequency of positive MLR's between unrelated individuals with two 
LD determinants in common (this report). 
e) variations of culture lengths suggest the influence of additional genetic sys-
tems on MLR (chapter 3). 
Therefore, in dogs as well as in mice (Mea et al. 1973) and in men (Mempel et al. 
1973, Suciu-Foca & Dausset 1975, Bijnen et al. 1976) the available evidence 
indicates a polygenic control ofthe MLR. If this new model is valid, each LD homo-
zygous reference cell should be submitted to a specificity analysis, since homo-
zygosity can be present for only one or more of the LD loci involved. It then 
follows that it is important to determine whether a typing cell is homozygous by 
descent or not, as homozygosity by descent automatically implies homozygos-
ity for all LD loci of the MHC. Phenomena described as "inclusion", "crossreact-
ivity" and "typing response" in LD typing can easily be explained by a multiple 
locus model. A further definition of the genetics and polymorphism in the con-
trol of the MLR will allow for a better identification of LD identical unrelated 
individuals, facilitating the analysis of the possible histocompatibility effect of 
LD loci in a preclinical model such as the dog. 
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CHAPTER 5 
GENETICS OF KIDNEY ALLOGRAFT SURVIVAL IN DOGS 
I Relevance of minor histocompatibility systems in 
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Summary 
To evaluate the importance of antigens not belonging to the canine major histo-
compatibility complex (MHC), the DLA complex, for renal allograft survival, 
kidneys were transplanted in various genetically different donor-recipient combin-
ations. No immunosuppressive therapy was given. Histocompatibility testing 
was performed by serology alone or in combination with mixed lymphocyte 
reactions (MLR's) in beagles and by serological typing and MLR's in mongrels. 
Renal allograft survival in DLA matched non-sibling beagles was significantly 
shorter than in DLA matched littermate beagles. A larger number of differences 
for non-DLA antigens in non-siblings compared to littermates is probably res-
ponsible for the discrepancy in survival times. The cumulative effect of these 
non-DLA antigens is comparable in strength to the DLA antigens, as the survival 
times in the matched non-siblings were close to the survival times in one haplo-
type mismatched littermates. 
Kidney allograft survival in DLA matched unrelated mongrels was still shorter 
than in DLA matched non-sibling beagles, possibly due to a larger heterogeneity 
of non-DLA antigens in mongrels. MLR and/or serologically matched beagles 
and MLR matched mongrels always survive significantly longer than MLR and 
serologically mismatched mongrels. 
The number and polymorphism of non-DLA systems, relevant for kidney 
allograft survival was calculated to be limited in beagles (three systems with 
three alleles each could explain the results). These observations may be relevant 
to kidney transplantation in man, as further improvements in the effect of histo-
compatibility matching may be obtained by pursuing attempts to match for 
antigens of as yet undefined non-MHC rather than MHC systems. 
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Introduction 
Matching donor and recipient for the serologically defined (SD) antigens of the 
major histocompatibility complex (MHC) drastically improves human kidney 
allograft survival in related donor-recipient combinations (1, 15, 20, 21 ). Match-
ing for these SD antigens improves kidney allograft survival to a lesser extent 
in unrelated donor-recipient combinations ( 4, 5, 14, 17, 18, 21, 23 ). An explan-
ation for the difference in efficacy of matching between related and unrelated 
donor-recipient combinations could be that the products of other genes within 
the MHC, different from the presently defined SD antigens, are more relevant 
for kidney allograft survival than the SD antigens themselves. An alternative 
explanation would be that the cumulative effect of non-MHC antigens, which 
is stronger in unrelated compared to related donor-recipient pairs, plays an im-
portant role in the determination of allograft survival. Finally, both hypotheses 
may be true and contribute each to the discrepancy in results of matching relat-
ed compared to unrelated individuals. 
A preclinical animal model such as the dog, in which an extensive immune-
genetical knowledge has been gathered in the past (9, 24, 26), is optimally suited 
for a further evaluation of the effect of histocompatibility matching on allograft 
survival. Studies in such an experimental model have several advantages over 
human studies. Immunosuppressive regimes can be standardized and uninten-
tional preimmunization for histocompatibility antigens can be more easily avoid-
ed. The selection of various genetically different donor-recipient pairs in dogs 
is relatively easy due to a somewhat limited heterogeneity in selected but still 
outbred breeds as the beagle (16) and a high standard of histocompatibility 
testing (9, 24, 26). 
Previous studies in our laboratory demonstrated that matching for the SD 
antigens of the canine MHC, the DLA complex, drastically improves renal 
allograft survival in unimmunosuppressed related beagles (28). Preliminary 
results regarding the relative influence of subregions of the DLA complex to 
renal allograft survival in unrelated mongrels have been reported earlier (29). A 
more extensive study, including the results of kidney allograft survival in DLA 
recombinants is described elsewhere (chapter 6). In this report, the relative im-
portance of non-MHC histocompatibility systems to renal allograft survival in 
unimmunized dogs is evaluated. Retrospectively, the possible role of sex-linked 
histocompatibility systems is investigated. A fairly large number of renal allo-
grafts were performed in unimmunosuppressed beagle littennates, making a 
reliable estimate of the number of minor histocompatibility systems and their 
alleles involved in the rejection of kidney allografts in this breed possible. 
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Material and methods 
Dogs 
Beagles were obtained from the colonies of the Centraal Proefdierenbedrijf TNO, 
Austerlitz, the Netherlands (Dr. J. van Vliet). Mongrels were obtained from local 
dog handlers and breeders. No predigrees were available for the mongrels. The 
chances of a close genetic relationship between these animals were decreased by 
appropriate instructions to the dog handlers, the collection of animals over a 
period of a year and the use of donors and recipients of different purchase dates. 
The pedigrees of the beagles were checked as far as possible (2-4 generations). 
No evidence for inbreeding was found. However, common ancestors were found 
in 9 out of 15 non-sibling donor-recipient combinations. 
Serology and experimental groups 
Serological testing was done with a battery of sixty to ninety alloantisera, using 
a one stage microlymphocytotoxicity test as described before (24). DLA match-
ing was performed using different methods in the following experimental 
groups. 
Group I were DLA identical littermate beagles in which no MLR was perfor-
med (n = 13 ). DLA haplotyping and matching was done by analyzing the segreg-
ation patterns of the typing sera in the families (24 ). 
Group 2 were also DLA identicallittermate beagles (n = 8). In this group SD 
matching was performed by means of segregation analysis and typing, i.e. by 
assigning SD specificities to the individuals. All pairs were MLR negative. 
Group 3 were non-sibling beagles (n = 6). They were assumed to be DLA 
compatible on the basis of the reaction patterns of the battery of antisera with 
the lymphocytes of the donor and recipient. Arbitrarily, dogs were called SD 
identical when less than five sera reacted differently (positively or negatively) 
in the microlymphocytotoxicity test with donor and recipient lymphocytes. 
Group 4 were SD and MLR identical non-sibling beagles (n = 9). SD match-
ing was performed by means of SD typing. 
Group 5 were SD and MLR identical unrelated mongrels (n = 5). SD com-
patibility was assessed by means of SD typing. 
Group 6 were SD and MLR different unrelated mongrels (n = 8). All were 
SD typed. 
Currently the SD antigens of the DLA complex are thought to be controlled by 
three loci. The antigens I, 2, 3, 7, 8, 9 and 10 belong to the first or DLA-A 
series; the antigens 4, 5, 6, 13 and R 20 belong to the second or DLA"B series 
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and the antigens II, 12 and R 15 belong to the third or DLA-C series. All series 
still have blanks and additional preliminary recognized antigens. Antigens num-
ber I to 13 have been confirmed by other workers and have been recommended 
for international use by the lUIS subcommittee for dog histocompatibility struc-
tures (Joint Report of the Second International Workshop on Canine Immuno-
genetics, 9). 
Mixed lymphocyte reaction (MLR) 
Unilateral cultures were performed as described previously (3). Identity for the 
lymphocyte defined (LD) antigens is based on the absence of significant stimul-
ation in MLR in the presence of positive controls. Part of the mixed lympho-
cyte reactions of the mongrels was performed by van den Tweel and co-workers 
in a slightly different technique (22). 
The following homozygous LD typing cells were available and used for the 
selection of unrelated DLA identical beagles (group 4): DLA-50, DLA-51, DLA-
52, DLA-53, DLA-54, DLA-55, DLA-56, DLA-57, DLA-58, Rl and R2. DLAplus 
a number refer to the nomenclature recommendations of the Second International 
Workshop on Canine Immunogenetics (9); R plus a number refer to homozygous 
typing cells which are presently only locally available (Rotterdam) and await a 
more official designation after international comparison. 
Kidney allografting 
Kidneys were transplanted to the iliac fossa as described before (28). A simul-
taneous bilateral nephrectomy of the recipients own kidneys was performed. 
None of the recipients was immunized for histocompatibility antigens by preg-
nancies, transfusions or other means. As the end point of graft survival was 
considered the postoperative day on which the animal died from renal insuffi-
ciency or when the serum creatinine rose above I 000 11 mole/!. Histological con-
firmation of rejection was always obtained. Technical failures were excluded 
from the analysis. 
Statistical analysis 
Survival data were analyzed statistically by means of one sided (P 1) or doubly 
sided (P d) Wilcoxon rank sum tests. Recipients surviving for more than !50 days 
were excluded for the calculation of mean survival times (m.s.t.'s) ± standard 
deviations. 
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Table 5. I. Prolonged kidney allograft survival in DLA identical siblings without immunosuppression in one 
laboratory 
Experiment 
2 
donor blood 
prior to 
grafting 
third party 
unrelated blood 
prior to grafting 
third party 
unrelated blood 
after grafting 
third party 
related blood 
prior to grafting 
placenta eluate 
prior to and 
after grafting 
total 
Reference 
12 
2,' 
N' mst ± sdb 
13 43,0 ± 12,5 
8 43,7 ± 18,0 
8 15,0 ± 19,8 
II 30,6±11,2 
10 34,4 ± 9,2 
5 30,5 ± 13,1 
3 30,4 ± 10,1 
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number of experimental animals studied, technical failures excluded 
b mean survival time± standard deviation, long survivors excluded 
this report 
d Bull et a!., in preparation 
own unpublished data 
f Obertop et al., in preparation 
g Jeekel et al., unpublished data 
h 95% confidence limits 10-29% 
Immunogenetic calculations 
Number of survivors> ISO days 
2 
2 
2 
2 
0 
According to the formulas of Simonson (19), modified from Newth (II), the 
proportion of sibling to sibling donor-recipient combinations, which may expect-
ed to be compatible for the histocompatibility systems is ("3 + ": n~ 11 "-9)L; the 
proportion of unrelated donor-recipient pairs, which may be expected to be histo-
compatible is (4" 3 3 l. In both formulas n is the number of alleles and L the 
number of allelic "series. For simplicity equal strength and frequency of the alle-
les and an equal number of alleles per series is assumed. The application of these 
formulas to the fraction of compatible pairs found in transplantation exper-
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Table 5.2. DLA-SD typing. MLR and renal allograft survival of the donor-recipient combinations of group 
2 and 4 
Dog (sex)3 DLA MLR 
Test-b Autol.b Maximalb survival 
Recipient Donor A B c value control response (days) 
Group 2 
D 6465 (Ml D 6466 (Ml 9 6,13? 12 5 4 405 19 
D 6513 (M) D6512(M) 2,9 5,6 11,12 2 401 31 
5522 (F) 5521 (F) 9 4,6 12 4 5 117 42 
6471 (F) 6472 (F) 2 5,13 11 2 3 397 46 
6472(F) 6471 (F) 2 5,13 11 2 2 214 53 
D 6466 (M) D 6465 (M) 9 6,13? 12 2 5 636 71 
D 5715 (M) D 5713 (M) 2,9 5,6 11,12 2 21 >150 
D 6210 (M) D 6208 (M) 7,8 5 11 148 >150 
Group 4 
D 55 (M) D 5701 (M) 2,9 5,6 II, 12 4 4 193 16 
691 (F)' D 57I2 (M)c 2,9 4,5 11,12 4 2 89 22 
D5701(M) D 5528 (M) 2,9 5.6 11,12 3 6 469 22 
b 5703 (Ml D 5528 (M) 2,9 5,6 II, 12 2 7 186 24 
652 (F) D 5477 (M) 2,9 4,5 11,12 3 4 257 29 
689(F)c D57I2(M)c 2,9 4,5 11,12 3 2 89 31 
D 57I4 (M)c D 5689 (M)" 9 4 12 4 3 63 34 
D 5712 (M)c 689 (F)" 2,9 4,5 11,12 3 4 290 36 
D 5689 (M)" D 57I4 (M)c 9 4 12 5 4 168 36 
a M ""' Male, F = Female 
b Counts per minute x 10-2 
c A common ancestor was found in the last 2-4 generations of the pedigree 
iments makes a rough estimate possible of the involved number of histocompat-
ibility systems and their alleles. For this estimate 58 kidneys, all transplanted to 
DLA identical unimmunosuppressed littermate beagles in our laboratory (table 
I), were considered as well as 15 kidneys from non-sibling donors (group 3 and 
4). 
Results 
Renal allograft survival in littermate and non-sibling dogs 
The results of DLA typing, MLR and graft survival of group 2 and 4 are pre-
sented in table 2. Group 5 and group 6 are only presented for comparison; 
the details of SD typing and MLR will be presented in chapter 5. Group 1 is 
published in more detail before (28). In the littermate donor-recipient combin-
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ations of group I, DLA identity was only assessed by means of serology. 
The DLA identity of the comparable dogs of group 2 was established by means 
of serological typing as well as by means of mixed lymphocyte reactions. Due 
to the low recombination frequency between the SD and LD loci (0.7%) 
no discrepancy in graft survival is expected when kidneys are taken from DLA 
SD matched or DLA SD and LD matched identical littermate donors. 
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Figure 5.1. Kidney allograft survival in 21 DLA-SD identicallittermate donor-recipient pairs. 
No significant difference is seen between MLR not tested (group 1) and MLR negative (group 
2) combinations. 
Figure I shows, that indeed no discrepancy is found (P1 = 0.22). In one recip-
ient a relative short survival time is seen of !9 days. However, the SD typing in 
that family was uncertain, thus an SD/LD recombination cannot be excluded 
with certainty. 
In the non-littermate donor-recipient combinations of group 3, DLA ident-
ity was only assessed by means of serology. The DLA identity of the compara-
ble dogs of group 4 was established by means of both serology and mixed 
lymphocyte reactions. Due to the strong linkage disequilibrium between SD and 
LD genes in beagles (SD identical beagles are almost always LD identical -7; own 
unpublished observations) no discrepancy in the results of these two groups is 
expected either. Figure 2 shows that the results of group 3 and 4 are striking-
ly similar (P1 = 0.33). Pedigree analysis (2-4 generations) of the donor-recipient 
combinations in group 3 and 4 demonstrated the presence of common an-
cestors in 9 out of the 15 combinations ( 4 out of 6 in group 3 and 5 out of 9 
in group 4. The mean survival time (m.s.t.) of the combinations in which 
common ancestors could be demonstrated was slightly longer than the m.s.t. in 
the combinations in which no common ancestors could be traced (m.s.t. 30.9 
compared to 26.2 days), but the difference was not significant (P1 = 0.15). 
The survival times of group 4 are compared with the survival times of group 
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1 and 2 and with the survival times of kidney allografts from one and two 
haplotype different litterrnate donors, which were performed in the same labor-
atory (28) (figure 3). It appears that renal allograft survival in DLA LD and SD 
identical non-sibling donor-recipient pairs is significantly shorter than in DLA 
identicallitterrnate donor-recipient pairs (P 1 < 0.0005); about as long as in one 
DLA haplotype different litterrnate combinations (P d = 0.41 ); and longer than 
in two DLA haplotype different littermate combinations (P d < 0.005). 
SD and LD matched unrelated (group 5) mongrel to mongrel donor-recipient 
pairs have a shorter survival than non-sibling SD and LD matched beagles (group 
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Figure 5.2. Kidney allograft survival in 15 DLA SD identical non-sibling donor-recipient pairs. No signifi-
cant difference is seen between MLR not tested (group 3) and MLR negative (group 4) 
combinations. 
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Figure 5.3. Kidney allograft survival in DLA matched non-sibling donor-recipient combinations and DLA 
identical, one haplotype different and two haplotypes different littermate donor-recipient 
combinations. The survival times in non-siblings are best comparable to those in one haplo-
type different donor-recipient combinations. 
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Table 53. Sex differences and renal allograft survival in unimmunized, not immunosuppressed, DLA 
matched littennate and non-sibling donor-recipient combinations 
Experiment sex3 Nb 
donor-+recipient 
I+ 2 M~M 9 
M~F 3 
F ~M 3 
F~F 6 
3+4 M~M 5 
M~ F 5 
F~M 2 
F~F 3 
3 M = male F = Female 
b number of experimental animals within each group 
c median survival times bold 
Survival timesc 
19,3! ,3!,35,4!,60,71 ,>ISO,> !50 
35,41,59 
42,48,65 
26,33,42,46,53,> !50 
16,22,24,34,36 
17,22,27,29,31 
36,39 
22,32,48 
4), P1 < 0.02 , The m.s.t.'s of groups I, 2, 3, 4 and 5 are all significantly 
longer than the m.s.t. of unrelated mismatched mongrels (P 1 for group I, 2, 3 
and 4 each< 0.0005, for group 5 < 0.02). 
Sex-linked histocompatibility 
In table 3, the data of group I and 2 are rearranged to permit a search for the 
possible presence of sex-linked histocompatibility antigens. Details of the method-
ology of such an analysis are described elswhere (25). Survival of male to female 
grafts was no shorter than survival of male to male grafts. This is in contrast with 
the expected shorter survival of male to female grafts in the presence of important 
Y-linked histocompatibility systems. Furthermore, survival of the female to 
male grafts was no shorter than survival of male to male and female to female grafts, 
and the distribution in these groups seems to be similar. This argues against an im-
portant influence of X-linked histocompatibility genes in this modeL 
The number of minor histocompatibility systems and their alleles 
It appears from table I, that 17% (95% confidence limits 10-29%) of the kidneys, 
transplanted to DLA identical littermates, survived longer than !50 days. This 
percentage presents the maximum number of pairs compatible for non-MHC an-
tigens. Figure 4a shows that a limited number of minor histocompatibility sys-
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terns with a small number of alleles (for instance two systems with four alleles, 
three systems with three alleles, or four systems with two to three alleles each) 
may explain the results. It can be calculated (see also figure 4b), that, based on 
this assumption, about 4% of compatible pairs are expected to be found in ran-
dom unrelated donor-recipient combinations. This fits with the observation that 
no prolonged survival times were found in non-sibling DLA identical beagle do-
nor-recipient pairs, i.e. 0% (95% confidence limits 0-20%) compatible pairs. 
Figure 5 .4. 
100 B 
7 11 13 5 7 11 13 
no. of ollele> no. of alleles 
Estimation of the number of minor histocompatibility systems and their alleles involved in 
the determination of renal allograft rejection. The found %of rejected kidneys with the 95% 
confidence limits are indicated in the figure. The curves represent the expected %of rejected 
kidneys as a function of the number of the alleles, assuming equal strength and frequency, for 
1, 2, 3 and 4 minor histocompatibility systems 
a. for renal allograft survival in 58 unimmunosuppressed DLA identical beagle littermate 
donor-recipient combinations. 
b. for renal allograft survival in 15 unimmunosuppressed DLA identical beagle non-sibling 
donor-recipient combinations. 
Discussion 
A considerable amount of knowledge exists on minor histocompatibility systems 
in mice. In that species, the cumulative effect of minor histocompatibility differ-
ences can equal the influence of MHC differences with regard to skin graft surviv-
al (6). However, little is known of the role of minor histocompatibility systems 
to allograft survival in other experimental models. Data in this area are needed 
for an estimate of the maximum benefit that can be obtained from matching for 
antigens of the MHC for renal allograft survival in unrelated human donor-recip-
ient pairs. 
The analysis of the results of kidney allografting experiments in a preclinical 
model such as the dog may provide a prognosis on the effect of matching for 
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more or different antigens of the MHC other than the usual SD antigens 
HLA-A, HLA-B and HLA-C, This study shows that highly reproducible results 
are obtained in littermate and non-littermate donor-recipient pairs. 
Furthermore, it is of interest to note that the similarity of this model with 
the results of small bowel grafting are striking (27). In that model the mean 
survival times were 7.6 days for unrelated mongrels, 27.5 days for non-sibling 
matched beagles and 45.3 days for matched littermate beagles. This indicates that 
the antigens involved in the rejection of small bowel and renal allografts are the 
same. 
Renal allografts have been performed in non-sibling beagles, because identity 
for the LD and for SD antigens in this race probably means identity for all anti-
gens of the DLA complex. This is suggested by the extremely strong linkage 
disequilibrium between DLA-A, -B, -C and -D genes (7, 9, 22, 26 and own un-
published data). This linkage disequilibrium is probably caused by a pronoun-
ced founder effect (26). Furthermore, common ancestors could be identified in 
most of the donor-recipient pairs, and might have been traced in the other don-
or-recipient combinations if a more extensive pedigree analysis could have 
been performed. 
The availability of non-sibling MHC identical beagles offers an excellent 
possibility for the determination of the relative importance of non-DLA versus 
DLA histocompatibility. Differences in non-DLA (minor histocompatibility) 
antigens will be less frequent in littermate compared to non-littermate donor-
recipient combinations. If indefinite numbers of alleles for all systems are ass-
umed, littermates will have 50% of their genome in common, while unrelateds 
will have nothing in common. In such a situation the number of minor histocom-
patibility differences in unrelated combinations will be twice the number of 
histocompatibility differences present in littermate combinations. In our exper-
imental situation, this would mean that the cumulative strength of non-DLA 
histocompatibility structures is comparable to that of the DLA histocompat-
ibility structures, as the graft survival in the one haplotype different littermate 
group (m.s.t. 23.8 ± 13.8 days) is comparable to the graft survival in the DLA 
matched unrelated group (m.s.t. 29.0 ± 8.8 days). As the number of alleles of 
the histocompatibility systems is found to be limited, the discrepancy between 
the littermate and non-littermate groups will be less; also additional accidental 
matches for non-DLA histocompatibility systems may be present in the non-
sibling group because donors and recipients are related. Both are reasons to 
assume that our estimate that the cumulative effect of non-DLA histocompat-
ibility systems is comparable to the strength of the DLA histocompatibility 
systems is an underestimate. This is illustrated by the observation that the sur-
vival times in SD and LD identical mongrels, which also may be identical for all 
antigens of the DLA complex, are still much shorter (m.s.t. 18.2 ± 4.6 days) 
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than in non-sibling beagles. A possible explanation for this finding is a greater 
heterogeneity of non-DLA histocompatibility systems in mongrels. It is possible 
that part of these non-DLA histocompatibility systems are loosely linked to the 
histocompatibility systems of the DLA complex, but proof for such a linkage 
is not available. 
The possibility that outside the DLA complex only a limited number of minor 
loci (for instance three autosomal loci with three alleles each) would control 
kidney allograft survival is rather unexpected in view of the many loci influen-
cing mouse skin graft survival. However, it should be realized that this is a 
(maybe slight) underestimate as 
a) the beagles are a selected breed with a somewhat limited heterogeneity 
b) incompatibilities for minor histocompatibility systems may occur in spite of 
prolonged kidney allograft survival and 
c) the involved alleles are unlikely to be of equal frequency and strength. 
On the other hand, the last possibility in particular makes attempts to match for 
minor histocompatibility antigens attractive. If two or three alleles were much 
stronger and more frequent than others, matching for their respective antigens 
might effect a prolongation of graft survival in a considerable number of recip-
ients. The logistics of matching for these antigens would however not be easy. 
Previous experience has shown that it is difficult to produce serological reagents 
recognizing minor histocompatibility antigens. However, the described observ-
ations call for all sera which are (I 0) or become available to be tested for their 
relevance to allograft survival in a controlled model. 
It has been shown that sex-linked genes may be of some importance in deter-
mining graft survival in unimmunized recipients (25). The data described here 
however do not show an important influence of sex-linked genes in the unimmun-
ized recipient. More extensive data are awaited before a decision can be taken 
on the usefulness of matching for sex for the selection of donor-recipient pairs 
for further experimental studies. 
In experimental animal studies, isolated weak histocompatibility differences 
appear to be easier to suppress with immunosuppressive drugs than strong histo-
compatibility differences. In humans, comparable data are lacking. Furthermore, 
there is no evidence that differences for weak histocompatibility systems can 
easily be suppressed if their cumulative effect is strong (8). In fact, data in 
human kidney allografting suggest that minor histocompatibility structures in 
related donor-recipient combinations are as strong as a one haplotype difference 
(15). Furthermore, it appeared that on the American continent HLA matching is 
not effective m centers with a good overall outcome of clinical cadaver trans-
plantation (13). This might indicate that with the optimal use of immunosup-
pression, differences for MHC antigens are as equally well suppressed as non-
MHC differences. 
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Observations in the beagle model indicate that the efficacy of current human 
selection procedures might be increased when more emphasis is placed on the de-
velopment of selection procedures for minor histocompatibility systems. Incom· 
patibility for such systems would be only of clinical relevance of they withstood 
regular, currently available immunosuppressive therapy. A proper evaluation of 
this problem requires the use of an experimental animal model. Therefore, invest-
igations to study the importance of different immunogenetic situations for 
renal allograft survival under immunosuppression in dogs are currently under-
way. 
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Summary 
To assess the relative importance of the subregions of the canine major histo-
compatibility complex (MHC) for renal allograft survival in recipients without 
immunosuppressive therapy, kidneys were transplanted in two experimental 
groups. The results in six beagle donor-recipient pairs in which the donor or recip-
ient had a recombination in the MHC, fit with a predominant role of the subreg-
ion which contains the major mixed lymphocyte reaction (MLR) locus. Results 
in unrelated mongrels also show that compatibility for MLR is more favourable 
for kidney allograft survival than compatibility for the serologically defined (SD) 
antigens. However, the effect of combined matching for MLR and SD antigens in 
unrelated dogs is slight in comparison to the effect of MLR and/or SD matching 
in related dogs. This indicates that other important histocompatibility systems 
must exist in this species. 
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Introduction 
Matching for the serologically defined (SD) antigens of the major histocompati-
bility complex (MHC) in sibling donor-recipient combinations drastically improv-
es human kidney allograft survival (3, 12, 15, 16). Matching for the SD antigens 
in unrelated donor-recipient combinations only slightly improves renal allograft 
prognosis (6, 8, 10, 13, 14, 16, 19). Thus, some parts of the MHC may be more 
important to allograft survival than others. 
To study the relative importance of the various subregions of the major histo-
compatibility complex (MHC), two methods are available. In the first place, ani-
mals with a recombination in the MHC can be used for renal allografting exper-
iments in related donor-recipient combinations. The sunrival times are indicative 
for the histocompatibility effect of the subregions on both sides of the crossing-
over site. The scarce availability of recombinants over long periods is a severely 
limiting factor to the performance of such studies in out bred species. Secondly 
unrelated donor-recipient pairs can be used which are identical for some but dif-
ferent for other defined markers of the MHC. The results of such studies have to 
be interpreted with care as matching for defined markers in the MHC may entail 
unintentional matching for undefined antigens, when linkage disequilibrium 
exists between alleles of the defmed and undefined genes of the MHC. 
The dog model has been developed over the last years as an animal model 
which is optimally suited to study the effect of histocompatibility matching on 
allograft survival (9, 20, 21, 22, 23). 
Preliminary results regarding the relative influence of matching for the prod-
ucts of the subregions of the DLA complex to renal allograft survival have been 
reported earlier (24). In this report a more extensive study including the results 
of kidney graft survival in DLA recombinants is presented, with special regard to 
the relevance of compatibility for the MLR or lymphocyte defined (LD) anti-
gens. 
Material and methods 
Dogs 
Beagles were obtained from the colonies of Ret Centraal Proefdierenbedrijf 
TNO, Austerlitz, the Netherlands (Dr. J. van Vliet). Mongrels were obtained 
from local dog handlers and breeders. No pedigrees were available for the mon-
grels. The chances of close genetic relationships between these animals were 
decreased by appropriate instructions to the dog handlers, the collection of ani-
mals over the period of a year, and the use of donors and recipients from differ-
ent purchase dates. 
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Serology 
A battery of seventy to ninety different alloantisera was used in a one stage 
. microlymphocytotoxicity test to type for the SD antigens as described before 
(20, 22). Currently the SD antigens of the DLA complex are thought to be 
controlled by three loci. The antigens I, 2, 3, 7, 8, 9 and 10 belong to the first 
or DLA-A series; the antigens 4, 5, 6, 13 and R 20 belong to the second or 
DLA-B series and the antigens I I, 12 and R 15 belong to the DLA-C series. 
All series still have blanks and additional preliminary recognized antigens. Anti-
gen number I to 13 have been confirmed by other workers and have been re-
commended for international use by the lUIS subcommittee for dog histocom-
patibility structures (Joint Report of the Second International Workshop on Ca-
nine Immunogenetics, 9). 
Mixed lymphocyte reaction 
Unilateral cultures were performed as described previously (4). Part of the mixed 
lymphocyte reactions of the mongrels were performed in a slightly different 
technique by van den Tweel and co-workers (17). The unrelated mongrels were 
presumed to be LD matched when the reactivity in MLR of the recipients lym-
phocytes as responder cells against the donors lymphocytes as stimulator cells 
was less than 20% of the maximal response in the same test. The following ho-
mozygous LD typing cells were available and used during part of this study: DLA-
50, DLA-51, DLA-52, DLA-53,DLA-54, DLA-55, DLA-56, DLA-57, DLA-58, Rl 
and R2. DLA plus a number refer to the nomenclature recommendations of the 
Second International Workshop on Canine Immunogenetics (9); R plus a number 
refer to homozygous typing cells which are presently only locally available (Rotter-
dam) and await a more official designation after international comparison. 
GT 
The determination and the genetics of the immune response against copolymers 
of L-glutamic acid with L-tyrosine (GT) in dogs is described elsewhere (22). In 
brief, the IrGT region was found to be linked to the DLA complex. The most 
probable chromosomal sequence is IrGT : DLA-D : DLA-A : DLA-B. 
Kidney a/lografting 
Kidneys were transplanted to the iliac fossa as described before (23). A simultan-
eous bilateral nephrectomy of the recipients own kidneys was performed. The 
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recipients were not immunized and received no immunosuppression or support-
ive therapy, except an SD/LD recombinant, which received inadvertently three 
blood transfusions from unrelated animals as part of another experimental pro-
tocol. This is not considered relevant for the interpretation of the results as trans-
fusions in this protocol did not prolong renal allograft survival (Bull et a!., in pre-
paration). The postoperative day on which the animals died from renal failure or 
when the serum creatinine rose above 1000 I" Mole/!, caused by immunological 
rejection of the graft, was taken as the end point of graft survival. Histological 
confirmation of rejection was always obtained. 
Kidney allografting was performed in the following experimental groups: 
a) Related, DLA recombinant beagles. 
Three dogs with a recombination in the MHC could be used for six donor-re-
cipient pairs: The kidney of an animal with a recombination between DLA-A 
and DLA-B was transplanted to a littermate which differed for one DLA-B 
antigen alone. The second kidney of the same recombinant was exchanged with 
the kidney of another sib which was identical to the first recipient. The MLR 
between the recombinant and the other two recipients was positive in both di-
rections. The SD/LD recombinant donated its kidney to an SD different LD 
identical sibling. A dog with a recombination between the MHC and the im-
mune response locus for GT (22), who was a "GT responder", exchanged kidneys 
with a DLA SD and LD identicallittermate, who was a "GT non-responder". 
b)Unrelated mongrels. 
Four different groups were grafted: 
Group 1: SD and LD identicals (n = 5); 
Group 2: SD different and LD matched dogs (n = 5); 
Group 3: SD identical LD different dogs (n = II); 
Group 4: SD different LD different dogs (n = 8). 
Statistical evaluation of the survival times was performed by means of one sided 
Wilcoxon rank sum tests. 
Results 
Recombinants 
Table I shows the result of the MLR of an individual with a recombination bet-
ween the DLA-A and -B loci with its parents, sibs and relevant typing cells. The 
test has been repeated twice with the same outcome. It is remarkable that the 
recombinant shows a low (but definite) stimulation with both its "three quart-
er" DLA identical sibs and both typing cells of the father. As the recombinant 
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00 Table 6.1. MLR of dog 05.687 with a paternal recombination between DLA-A and several members of its family 
Dog SO genotyping D2.175x 2.292x 05.687 X D5.690x 05.691/ D5.688x D5.689x 
02.175 A9-B4-C12/A7-B--C- I(± 33%)b 23(±10%) 16 (± 13%) 19 (± 10%) NT' I(± 24%) l (±56%) 
(father) 
2.292 A9-D4-C12/A3-B--C- 10 (± 16%) ( (± 72%) 5 (± 23%) I(± 38%) NT 1 (± 35%) I(± 51%) 
(mother) 
D5.687d A9-D-C-/A3-B--C- 33 (± 5%) 9 (± 28%) 0(± 14%) 5 (±49%) 40 (± 32%) 10 (± 16%) 7 (± 19%) 
(recombinant) 
05.690 A9-B4-C12/A3-B--C- 13 (±II%) 0 (± 60%) 5 (± 14%) 0 (± 37%) 0 (± !0%) I (± 9%) 0 (± 38%) 
05.691" A9-B4-C12/ A3-B--C- NT NT 38(±17%) 0 (± 21%) 0 (± !0%) NT NT 
05.688 A9-B4-C12/A9-B4-C12 !3 (± 14%) 9 (± 38%) 13 (± 15%) 6 (± 28%) NT 0 (± 40%) 0 (± 35%) 
05.689 A9-B4-C12/A9-B4-C12 II(± 8%) 6 (±41%) 12 (± 9%) 5 (± 18%) NT 0(± 70%) I(± 16%) 
Unrelated A9-B6-CI2/A2-B5-Cll 42(± 9%) 12 (± 7%) 8 (± 26%) II(± 14%) NT 8 (± 23%) 6 (± 19%) 
58hz and R2 hz: homozygous typing cells specific for the father 
b cpm x 10-3 (±standard deviation%) 
NT: not tested 
d The positive reaction with both paternal typing cells (58hz and R2 hz) can be explained by the assumption of two loci for MLR 
Test results of 05.691 were obtained in a separate test. 
Table 6.2. MLR of SO/LD recombinant 4.341 wilh four sibs 
Dog SD genotyping 4.341x D4.339x D4.335x 
4.341 A9-B4-C12/A2-B5 -Cll 3"(± 9%) 3 (± 24%) 17(±32%) 
0 4.339 A9-B4-C12/A9-B4 -Cl2 2 (± 74%) 5 (±58%) 17 (± 42%) 
D 4.335 A9-B4-C12/A2-B5 -Cll 3 (±II%) 4 (± 31%) 3 (± 15%) 
0 4.342 A9-B4-CI2/A1-Bl3-C~ 3 (± 2%) 5 (±53%) 13 (±41%) 
D 4.337 A2-B5-Cl !/Al-B13-C- 20 (±31%) 25 {± 23%) 28 (.± 60%) 
"cpm x 10"2 (±standard deviation%) 
Unrelatedx 58 hzx R2 hzx" 
49 (± 7%) 1 (± 35%) I (± 28%) 
15 (± 12%) I (±38%) 3 (± 16%) 
12 (± 33%) 8 (± 27%) 5 (± 20%) 
16 (± 7%) I (± 35%) 3 (± 16%) 
NT NT NT 
22 (± 2%) 0(± 70%) 3 (± 66%) 
25 (± 14%) 0 (±56%) I(± 39%) 
I(± 56%) 8 (± 2fl%) 4 (± 6%) 
D4.342x D4.337x 
17(±32%) 40 (.± 26%) 
12(±30%) 53(± 35%) 
13 (± 19%) 21 (± 34%) 
3 (± 47%) 33 (± 62%) 
15 (± 38%) 4 (± 32%) 
Table 6.3. SD typing, GT response and MLR of DLA-0/IrGT recombinant 2.207 
Dog GT response 2.207x 2.208x DR013 X 
2.207 Al-B- .C-/A7-B4.C- 2a(± 60%) 2 (± 38%) 95 (± 9%) 
2.208 + Al-B- -C-/A7-B4-C- 2 (± 65%) 1 (± 36%) 75(±11%) 
DROl3 NT 66 (± 19%) 46 (± 20%) 3 (± 37%) 
a cpm x l0"3 (±standard deviation%). 
is not immunized, the outcome of the test can only be explained by assuming at 
least two loci for MLR. 
Table 2 shows the MLR results of the SD/LD recombinant. Dog 4.341 is SD dif-
ferent from its homozygous sib D 4.339, but is identical in MLR; he is also SD 
identical with its sib D 4.335 but different in MLR. Thus, the kidney grafted 
from 4.341 to D 4.339 was SD different but LD identical. 
Table 3 shows that the GT recombinant 2.207, which was a "GT non-respon-
der", was SD and LD identical with its littermate 2.208, which was a "GT res-
ponder". 
Table 6.4. Kidney allograft survival in DLA recombinant donor- recipient combinations 
Recipient Donor Recombinant site Survival time (days) 
D5.69l D5.687 DLA- A/B lO 
05.690 05.687 DLA- A/B ll 
05.687 D5.69l DLA- A/B ll' 
2.207 2.208 DLA- D/ !rGT 19 
2.208 2.207 DLA- D/IrGT 31 
4.342 4.341 LD/SD >300 
dog 05.687 died from a volvulus with a nonnal serum creatinine but clear histological signs of rejection 
The survival times of the kidney allografting experiments of these recombinants 
are given in table 4. Dog D 5.687 died on the II th postoperative day from a vol-
vulus with a normal serum creatinine. However at histological examination of 
the graft severe signs of rejection were seen. Therefore it is reasonable to assume 
that otherwise he would have died of uremia in about another week. The survival 
times of the recombinant donor-recipient combinations are significant shorter 
than those of the DLA identicallittermate donor-recipient combinations (see fig-
ure 1), which are described in greater detail elsewhere (23; chapter 5) (p = 0.01 
including D 5.687 as 18 days; p = 0.03 excluding D 5.687). The MLR compat-
ible recipients live longer than the MLR different recipients. 
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Figure 6.1. Genetic structure of the major histocompatibility complex in the dog and kidney allograft 
survival in six "three quarter" identical littermatc donor-recipient pairs compared with the 
control groups of full-house DLA identical sibs and one DLA haplotype different sibs. 
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Figure 6.2. Kidney allograft survival in unrelated mongrel dogs in different donor-recipient combinations. 
Unrelated mongrels 
Table 5 gives the typing results of the four different groups of unrelated donor-
recipient pairs. The survival times are illustrated in figure 2. The LD matched in-
dividuals survive significantly longer than the LD mismatched individuals (group 
1 versus group 3, p = 0.001; group 2 versus group 4, p = 0.04; group I + 2 
versus group 3 + 4, p < 0.001 ). SD matching alone does not improve graft 
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Table 6.5. SD typing; MLR results and kidney allograft survival times in SD = LD =(group I), SD =I= LD =(group 2), 
SD = LD =I= (group 3), and SD =I= LD =I= (group 4) unrelated donor-recipient pairs 
SD typing 
Recipient Donor 
Dog (sex)a DLA DLA MLR 
Recipient Donor A B c A B c Testb Autoi.b Maximalb Survival 
value control response days 
Group I 
139H (M) 04 (F) 3. 9 4 3, 9 4 6 2 588" 14 
1308 (M) R219 (F) 3, 9 6 3, 9 6 0 735c 16 
033 (F) 021 (F) 3 12 3 12 2 1 641" 17 
021 (F) 033 (F) 3 12 12 6 4 416" 18 
1400 (M) 1342 (M) 3 5.10 5.10 13 16 748" 26 
Group 2 
0705 (M) 0144 (F) 1' 2 5J3 11 2,10 5 11 14 3 71 10 
073 (M) 1358 (F) 3. 9 4 3, 1 4 11 18 8 885c 12 
1358 (F) 073 (M) 3, 1 4 11 3, 9 4 4 2 587c 14 
1401 (M) 1338 {F) 3 5,13 11 3, 9 5,13 1 4 860" 15 
0144 (F) 0705 (M) 2,10 5 11 L 2 5,13 11 12 2 67 18 
Group 3 
036 (M) 1364 (M) 7,10 5,13 7,10 5,13 1589 1589" 1 
1364 (M) 036 (M) 7,10 5,13 7,10 5,13 1497 2 1497" 8 
1407 (M) 1392 (F) 9 4, 5 9 4, 5 1125 3 1668" 8 
1392 (F) 1407 (M) 9 4. 5 9 4. 5 813 2 813 9 
1255 (M) 012 (M) 3. 1 5,13 3, 1 5,13 461 872" 10 
023 (F) 1357 (F) 3, 1 12 3, 1 5 12 732 21 1527c 10 
0145 (M) 5455 (F) 2. 9 4, 5 11,12 2. 9 4, I 1,12 161 3 161 11 
5455 (F) 0145 (M) 2. 9 4. 5 11,12 2. 9 4, 11,12 131 6 209 12 
5456 (F) 0145 (M) 2. 9 4. 5 11,12 2. 9 4. 11,12 133 1 211 12 
0704 (M) 0142 (F) 2, 9 4, 11,12 2, 9 4. 11,12 149 4 149 12 
0706 (M) 0142 (F) 2, 9 4, 11,12 2, 9 4, 11,12 161 9 248 12 
Group 4 
DR222 (M) R220 (F) 3, 9 6 12 2. 3 11 330 631" 
5478 (F) 0143 (M) 9 4. 6 IIJ2 10 6 78 2 119 8 
R220 (F) DR222 (M) 2. II 3, 9 6 12 135 522" 8 
1345 (M) R220 (F) 3 11,12 2. 3 5 11 695 695° 9 
0707 (M) 0141 (M) 9 4, 6 11,12 10 6 45 2 65 12 
0141 (M) 0707 (M) 10 6 9 4, 6 11,12 18 2 26 12 
688 (F) 0141 (M) 9 4. 6 11,12 10 6 61 2 80 13 
0143 (M) 05209 (M) 10 6 9 4, 6 12 3 112 14 
a M = Male, F =Female 
b counts per minute x 10-2 
c MLR performed by van den Tweel and co-workers 
survival significantly: group 3 versus group 4, p = 0.39; group 1 + 3 versus 
group 2 + 4, p = 0.45, but a slight improvement of graft survival is seen in LD 
matched combinations (group 1 versus group 2, p = 0.07). 
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Discussion 
Matching for LD rather than for SD antigens of the MHC may improve human 
kidney allograft survival according to some authors (5, 8, II). These data are 
supported by the results of experimental kidney allografting in dogs (I, 24) and 
rhesus monkeys (13), but not in rats (7) or pigs (2). 
The results of the kidney allografting experiments in the recombinants report-
ed in this study support the hypothesis that the subregion of the MHC, in 
which the locus is found that codes for the DLA-D antigens, plays a predomin-
ant role in the determination of renal allograft survival. This can be clarified on 
behalf of the current concept of the DLA complex (figure I). The survival times 
of these kidneys allografts are expected to be in the range of DLA identical sibs 
or DLA one haplotype different siblings. The survival times of D 5.691 and D 
5.690 (and D 5.687) only fit in the DLA one haplotype different group. This 
means that an important histocompatibility gene is located to the left of DLA-B on 
the figure. The prolonged survival ofB 4.342 only fits in the DLA identical group. 
This means, that important histocompatibility structures are located to the left of 
DLA-A on the figure. The intermediate short survival times of B 2.207 and 
B 2.208 fit in both DLA identical and DLA one haplotype different groups. 
No GT studies were performed in these control groups; therefore recombin-
ations between DLA-D and IrGT cannot be excluded. Thus, it is possible that im-
portant histocompatibility genes are located left to DLA-D on the figure, and 
that the shortest survivors in the DLA identical group had such a recombination 
between DLA-D and IrGT too. Thus, if one would prefer to adhere to the 
. hypothesis, that only one gene or subregion of the MHC has a predominant role 
in the determination of renal allograft prognosis, than such a gene (or subregion) 
should be located outside DLA-A-B-C-D, close to DLA-D. Of course, on the 
basis of these limited data, the presence of more loci with an important role for 
renal allograft survival within the same region cannot be excluded. 
The data in unrelated mongrels show that matching for MLR improves graft 
survival significantly, while matching for SD antigens alone does not. A slight 
beneficial effect of SD matching may be seen in MLR compatible donor-recip-
ient combinations (compare group I with group 2). However the difference 
between these groups may also be caused by slightly higher MLR test values in 
group 2 compared to group I. The effect of combined SD and LD matching 
in unrelated mongrels (median survival time = 17 days) is disappointing 
when compared with the effect of DLA matching in littermate donor-recipient 
pairs (median survival time= 42 days) (23; chapter 5). 
Several explanations for the discrepancy between unrelated and related 
matched groups are available. One hypothesis is, that not the DLA-D locus itself 
but another locus (or loci) of the MHC is important for graft survival. If such 
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"major" graft prognosis loci were in linkage disequilibrium with the genes con-
trolling MLR, identity for DLA-D would often result in partial identity for the 
"major" graft prognosis antigens. Complete identity however would be more 
rare. In this way LD matching would contribute to a slight improvement of graft 
prognosis. Another possibility is that the LD loci have a histocompatibility eff-
ect per se with respect to renal allograft survival and that the discrepancy with 
the DLA identical littermate group is caused by a greater degree of incompat-
ibility for minor histocompatibility antigens in the unrelated donor-recipient 
pairs. These different hypotheses are discussed in more detail in chapter 5. 
The renal allografting experiments described in this report are performed 
without the use of immunosuppression. It is possible that with the use of these 
drugs the histocompatibility effect of some antigens will become more pronoun" 
ced than without these drugs. Therefore, histocompatibility studies with the 
use of immunosuppressive drugs are needed for a more extended evaluation of 
the relevance of matching for subregions of the MHC to kidney allograft survival. 
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CHAPTER 7 
GENERAL DISCUSSION 
7 .1. The MHC, its subregions and donor selection 
A large number of factors determine whether a kidney transplantation will be a 
successful operation or not (Kincaid-Smith, 1977). As many kidneys are trans-
planted yearly, gradually more of these factors are being identified. The quality 
of the donor kidney for instance appears to be a significant factor, as donor age 
(Kissmeyer-Nielsen and Kristensen, 1977) and method of kidney preservation 
(Opelz and Terasaki, l977f) are both reported to influence renal allograft surviv-
al rates. The capability of the recipients immune system to amount an immune 
response against the allograft and the immunization status of the patient are also 
important parameters (van Hooff et a!., 1972; Opelz et a!., 1973). Finally of 
course the degree of histoincompatibility between donor and recipient is import-
ant, as it determines the amount of immunosuppressive drugs needed to prevent 
the rejection reaction ( §I. 2.3 ). 
Compatibility for the gene products of the MHC is of an enormous importance 
for renal allograft prognosis, at least when donor and recipient are related (van 
Rood et a!., 1967; Sin gal et a!., 1969; Brynger et a!., 1977; Opelz et a!., 1977C; 
1977e; Solheim et a!., 1977). In sibling donor-recipient combinations compat-
ibility for all gene products of the MHC can be achieved by matching donor and 
recipient for only some of these gene products, namely by matching for the SD 
and LD antigens. However, the MHC contains many, maybe hundreds, of loci; 
only the gene products of a dozen of the loci of the MHC can presently be iden-
tified in man (e.g. Bach and van Rood, 1976). Until now mainly the relevance of 
matching for SD and LD antigens for cadaver kidney transplantation has been 
studied. Matching for the SD antigens slightly improves the overall outcome of 
cadaver renal allograft survival (van Hooff et a!., 1972; Dausset et al., 1974; 
Scandia transplant report, 197 5; Festenstein et a!., 1976; Opelz eta!., 1977a; Sol-
heim et a!., 1977). This effect is more pronounced in some subsets of patients, 
for instance recipients with circulating antibodies, males and non-blood group 0 
recipients (van Hooff, 197 6; Opelz and Terasaki, 1977f). Compatibility in the 
MLR is also associated with a favourable graft outcome (Cochrum et a!., 1973; 
Festenstein eta!., 1976; Opelz and Terasaki, 1977d). 
A more extensive knowledge exists on the role of the various subregions of 
the mouse MHC (the H-2 complex) with regard to skin graft survival (Klein, 
1975). In these species, many different congenic strains are available which 
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sometimes differ for only one subregion of the H-2 complex_ This makes a rather 
accurate assessment of the role of the various subregions of the H-2 complex 
possible. It appears that at least 3 different subregions of the mouse MHC have 
important histocompatibility effects, namely the K, I and D region. The possibil-
ity that other subregions contain weak histocompatibility antigens cannot be 
excluded. 
In larger species a detailed knowledge of the role of the subregions of the 
MHC is more difficult to obtain. Congenic strains are not available. The inform-
ation has to be gathered by grafting rarely occurring MHC recombinants and 
by grafting unrelated individuals with defined MHC differences. However, a 
strong linkage disequilibrium exists between various defined genes of the MHC 
in many species. Thus possibly a linkage disequilibrium also exists between 
defined and undefined genes of the MHC. Consequently, if donor and recipient are 
matched for defined MHC antigens, they may also be compatible for as yet 
undefined antigens. Thus, the effect of histocompatibility matching in unrelat-
ed donor-recipient combinations has to be interpreted with care, as a prolong-
ation of graft survival obtained by matching for defined MHC antigens may or 
may not be caused by unintentional matching for undefined MHC antigens. The 
results of renal allografting in man are difficult to analyze because of the many 
uncontrollable variables which may play a part, such as different drug protocols, 
different status of pre-existent immunization, graft loss from technical reasons, 
differences in crossmatch techniques and inaccurate typing of the donor. Many 
factors now are known to influence the results (Kissmeyer-Nielsen and Kristen-
sen, 1977). However, many more variables probably are still to be discovered. 
Therefore studies in a well defined preclinical animal model, performed under 
standard conditions in one laboratory, may help to solve questions which are 
difficult to answer in humans. 
Previous experiments in dogs (Westbroek et al., 1975) and rhesus monkeys (van 
Es et al., 1977) have shown the superiority of LD matching over SD matching 
with regard to renal allograft survival. In this thesis, the importance of compat-
ibility for MLR and for the whole MHC to renal allograft survival has been 
further explored in dogs. The influence of immunosuppressive therapy has 
been deliberately excluded by omitting immunosuppressive drugs in any of the 
studies. 
7 .2. MLR and donor selection in dogs 
7.2.1. MLR and renal allograft survival in dogs 
Compatibility for defined as well as for undefined antigens may be important 
for renal allograft survival. The experiments reported in chapter 6 of this thesis 
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show that matching for SD antigens is of little influence when donor and recip-
ient are unrelated mongrels and when no immunosuppressive therapy is used. 
In the same model, compatibility for MLR significantly improved renal allograft 
survival. Also the studies in recombinant related beagles suggest a predominant 
role of the LD loci for graft rejection. The possibility that not the LD loci them-
selves but other loci, closely linked to DLA-D and in linkage disequilibrium with 
this locus, are relevant for graft survival, cannot be excluded. 
The prolongation of renal allograft survival, obtained by matching for MLR, 
in unrelated mongrels was, though significant, only slight when compared with 
matching for the whole MHC in littermate beagles (chapter 5). Several reasons 
may account for the shorter survival times in unrelated MLR negative mongrels 
compared to sibling beagles. In the first place, kidney allograft survival has not 
been studied in unimmunosuppressed DLA identical sibling mongrels. It is very 
well possible, that mongrels are more heterogeneous than beagles and that conse-
quently the cumulative effect of differences for non-MHC histocompatibility 
systems is stronger in related and unrelated donor-recipient pairs in mongrels 
than in beagles. This is suggested by the longer kidney allograft survival times in 
SD and LD identical non-sibling beagles than in mongrels (chapter 5). If this is 
true, then the kidney allograft survival times in DLA identical sibling mongrels 
can expected to be shorter than in the comparable beagle group. Thus, the dif-
ference in survival times between MLR negative unrelated and sibling mongrel 
donor-recipient pairs would be less. A second possibility which might explain 
why the effect of matching for MLR in the unrelated donor-recipient pairs is 
only slight is that the sensitivity of the used MLR technique was insufficient. It 
is shown in the next paragraph, that this explanation is improbable. Finally 
other genetic systems (which may be located within the MHC, outside the MHC 
on the chromosome which carries the MHC, or on other chromosomes) may 
exert a considerable influence on renal allograft survival. These possibilities are 
discussed in § 7.3 and § 7 .4. 
7.2.2. Applications of the MLR 
The MLR can serve different purposes. In the first place, the assay can be used 
to test the presence of a difference for MLR antigens. If in vitro cellular proli-
feration and blast formation occurs, the test outcome is called positive. It means 
that responder and stimulator carry different MLR antigens. If no in vitro pro-
liferation and blast formation occurs, the test outcome is called negative. Then 
no detectable LD differences are present between responder and stimulator. 
From the studies described in chapter 3 it appeared, that in our technique, for 
an unambiguous qualitative discrimination between a negative and a positive test, 
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harvesting should be performed relatively late in culture, preferably on the sixth 
or seventh day. Whtn harvesting is performed earlier in culture, false negative 
reactions may occur. 
Secondly, the MLR may be used to measure the strength of the antigenic dif-
ference between responder and stimulator. For such a quantitative use of the 
test harvesting should be preferably performed earlier in culture, namely on the 
fourth or the fifth day of culture in our technique. With such a relatively short 
incubation period test reproducibility is better than with a longer incubation 
period; furthermore the results probably reflect the genetic differences between 
responder and stimulator more accurately when a shorter culture period is 
used. In the experiments described in chapter 6, the MLR 's were harvested on 
day 6 or 7. Thus a sufficient discrimination between negative and positive com-
binations was made. The MLR's in the SD and LD identical donor-recipient com-
binations were completely negative. Thus, no better correlation between MLR 
and renal allograft survival would be expected, if a more quantitative MLR test 
were used. 
72.3. LD typing methods 
The MLR can also be used for the determination of LD phenotypes. LD typing may 
be helpful for the selection of MLR compatible individuals. For this purpose 
homozygous typing cells (HTC's) are required. A one way negative reaction of 
the cells of the tested individual with a reference cell which is homozygous for 
a given LD determinant indicates that this individual carries that LD determi-
nant too. When population studies with HTC's are performed in humans, a 
dichotomy of high and low responses against various typing cells is observed 
(Grosse-Wilde et a!., 1975a; Keuning eta!., 1975b). Completely negative react-
ions are scarcely seen. Therefore in these studies it is assumed that individuals 
carry a given LD determinant when they show a one way low positive reaction 
with the typing cell. Such a low one way reaction is called a typing response. 
The results of LD typing with HTC's both in man (van Rood, 1978; Keuning, 
1978) and dogs (chapter 4) is disappointing as individuals with an identical LD 
typing are frequently MLR positive. 
Typing for MLR using homozygous reference cells is a time consuming and 
cumbersome method. Other methods are being developed to replace this test. 
One method is the primed lymphocyte test(PLT) (Sheehy et al., 1975). For this 
test in vitro sensitized lymphocytes are used as responder cells. Upon restimul-
ation with the same antigen, which was used for primary sensitization, an acceler-
ated response is obtained. This test has three advantages over the conventional 
MLC typing method. It takes only 24-48 hours to determine the LD phenotype 
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of an individual. Furthermore, with this method other cells, such as kidney cells 
or tumour cells which cannot react themselves by a specific proliferation in a 
mixed culture, can be typed too. Additionally, LD determinants can be recog-
nized with this method, which cannot be recognized with the HTC method 
(Bradley et al., 1977). Preliminary results with the PLT in dogs indicated that 
the test may become a useful tool for LD typing in this species (Lansdorp, perso-
nal communication). The possible role of the PLT for donor selection still has to 
be investigated. 
Typing forB cell antigens or !a like antigens may be another method to select 
LD identical individuals. Some of these B cell antigens are highly associated with 
LD antigens or may even be identical to them (van Rood et a!., 1978; Terasaki 
et a!., 1977). B cell typing is well developed in mice, man and rhesus monkeys 
(e.g. Shreffler and David, 197 5; van Rood et a!., 1977; Bainer et a!., 1977), but 
not in dogs. Individuals which are identical forB cell antigens are more frequent-
ly MLR negative than individuals which carry different B cell antigens. However 
an MLR of B cell antigen identical individuals can be strongly positive (van Rood, 
1978). B cell typing is done by serological methods. Therefore, B cell typing 
can be used as a matching procedure for cadaver kidney transplantation. 
The need for new methods to select LD identical individuals for transplant-
ation experiments is probably less urgent in dogs than in other species. In the first 
place, the strong linkage disequilibrium between SD genes and LD genes has the 
consequence that SD matched unrelated individuals are often automatically LD 
compatible. Furthermore, the short generation time of the dog allows breeding 
of homozygous reference dogs of all wanted LD types. However, the develop-
ment of new techniques for LD typing may still be useful for a further elucid-
ation of the genetics of the MLR and a better understanding of its role in trans-
plantation immunology. 
7.2.4. Genetics of the MLR in dogs 
The family studies described in chapter 4 and chapter 6 indicate that the canine 
MHC contains at least two loci which control the outcome of the MLR. In the 
mouse, at least five loci of the H-2 complex govern the outcome of the MLR 
(Meo et al., 1973). Thus it can be expected, that in analogy with the mouse 
model, more MLR loci will be discovered in the dog. Unfortunately, recombin-
ations in the canine MHC are only scarcely found. Therefore, such detailed 
knowledge on the control of the MLR in dogs is difficult to obtain. 
Population studies demonstrated the large polymorphism of LD systems in 
dogs (van den Tweel eta!., 1974; Grasse-Wilde et al., 1975b). Eleven different 
homozygous typing cells are presently available (chapter 4). Gene frequencies 
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Table 7 .I. Gene frequencies and linkage associations of presently recognized LD types as calculated by Grosse-Wilde et a!. (197Sb) 
LD type Source 
50 Munich 
51 Munich 
52 Munich 
53 Munich 
54 Rotterdam 
55 Rotterdam 
56 Munich 
57 Paris 
58 Rotterdam 
Rl Rotterdam 
R2 Rotterdam 
NT not tested 
11 29 haplotypes studied 
p-value > 0.05 
%occurrence on 
independent haplotypes 
Mongrel Beagle 
N=64 N=66 
14 15 
6 !5 
6 26 
14 9 
12 0 
31 3 
NT' !4b 
NT NT 
NT NT 
NT NT 
NT NT 
6's with SD antigens 
Mongrel Beagle 
50-4 .561" 50-2 .542c 50-4 1.170 
51-2 1.148 51-5 l .285 
52-4 .439 52-9 1.561 52-6 1.912 
53-3 .812 53-3 .923 
54-I 0: .625 54-5 .547c 
55-3 :1.894 55-11: .488c 
56-I .909 56-13: .909 
frequently 
associated 
SD haplotypes 
2- 4 
2- 5 
9- 6 
3--
10- 5 
3-11 
1-13 
8-13 
9- 4 
7-13 
7--
and delta values for linkage disequilibrium were calculated for only part of them, 
by Grosse-Wilde (1975a). Table 7.1 presents some gene frequencies and linkage 
associations in beagles and mongrels. No population studies were performed with 
DLA-57, DLA-58, Rl and R2. These latter typing cells were used to type families 
for the detection of recombinations which otherwise might not have been de-
monstrated. 
It should be realized that in dogs ahnost all available typing cells are homozy-
gous by descent. This implies that they are homozygous for both MLR loci. 
Thus the "LD type" which they represent may be the combination of the prod-
ucts of two loci. In other words, with the use of the presently available typing 
cells, typing will be often done for the products of two loci of an individual by 
means of one typing cell. On the other hand, if an individual carries one LD de-
terminant of the typing cell, but not the other, probably no one way negative 
reaction will be seen. 
Consequently, an efficient analysis of the populanon genetics of the separate 
LD loci each and their relevance to homografting can only be made if reagents 
are available which react with the products of only one locus. At present, such 
reagents are not available for dogs. Theoretically, they can be obtained by three 
different methods: 
a) a search for homozygous reference cells, which are "empty" at one locus, 
b) the generation of PLT cells against siblings with a recombination in the MHC 
and 
c) the development of antisera against the gene products of one locus. 
When such reagents become available this may have important consequences. 
For instance, it might appear that the gene products of one locus (e.g. the 
DLA-D locus) are more important for donor selection than the gene prod-
ucts of other LD loci. If the two locus model would be applicable to man, 
than it could provide a possible explanation for the fact that some kidneys are 
not rejected in spite of a strongly positive MLR (e.g. Opelz and Terasaki, 1977d). 
Identity for the gene products of the LD locus which is important for allograft 
survival could be masked by a concomitant difference for the LD locus which 
is not relevant for allograft survival. 
It is disappointing that in spite of all efforts to develop methods to select 
MLR compatible unrelated donor-recipient pairs, only a slight effect of matching 
for MLR on renal allograft survival is seen in our experiments. However, it is 
possible that matching for MLR becomes more important when the recipients 
are treated with immunosuppressive drugs. All the same one has still to take into 
account the possibility that besides the LD systems many other histocompatibil-
ity systems exist, which collectively determine whether a kidney homograft will 
be rejected or not. 
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7.3. Other genetic systems of the MHC and donor selection in dogs 
7.3.1. Serologically defined antigens 
The SD antigens are probably the best defined antigens of the MHC in dogs. Typ-
ing for these antigens is of the utmost importance for the selection of defined 
related donor-recipient combinations. Unfortunately identity for only these an-
tigens in the absence of a negative MLR does not prolong allograft survival when 
the donor is unrelated (chapter 6). Nevertheless the SD antigens are very useful 
markers for the selection of unrelated donor-recipient pairs because of the very 
high linkage disequilibrium between the SD and LD antigens in dogs (van den 
Tweel eta!., 1974; Grosse-Wilde eta!., 197Sb; own unpublished observations). 
Matching for SD antigens in man significantly improves cadaver donor renal 
allograft survival (chapter l, § 1.4.2). This observation does not contradict the 
observation in dogs that SD matching in LD mismatched individuals does not 
prolong graft survival (chapter 6). In this group of dogs, the concomitant mis-
match for LD antigens considerably reduces the chances of an accidental match 
for transplantation antigens which can be in linkage disequilibrium with the LD 
antigens. In the rhesus monkey similar results have been obtained, i.e. SD ident-
ity is not associated with a prolonged kidney allograft survival in contrast to LD 
identity (van Es et a!., 1977). The experiments should be repeated with the use 
of immunosuppressive drugs for a more definitive assessment of the value of 
identity for SD antigens alone for renal allograft survival. 
7.3.2. Other defined markers of the canine MHC 
Studies with bone marrow transplantation in dogs suggested the existence of a 
separate gene which determines allogeneic resistance against bone marrow grafts 
(Vriesendorp eta!., 1975b). This gene is in all probability located between the 
SD and the LD genes of the DLA complex. No in vitro assay for the determin-
ation of this genetic trait is yet available. 
As in humans, the locus for the polymorphic enzyme marker phosphogluco-
mutase-3 (PGM3) in dogs is linked to the MHC (Meera Khan et al., 1978) The 
exact localization of the PGM3 locus is unknown but it has to be located outside 
the DLA complex. No role for donor selection of this marker has yet been de-
monstrated. 
So far, attempts to identify !a genes in dogs have been unsuccessful (Vriesen-
dorp eta!., 1977b). Renal allografts performed in rhesus monkeys in !a identical 
MLR positive donor-recipient pairs did not reveal an important influence of 
compatibility for these genes alone on allograft survival (Bainer, personal com-
munication). Because of the similarities between the MHC of rhesus monkeys 
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and the canine MHC no separate role of compatibility for Ia antigens for graft 
survival would be expected in the comparable dog model. 
Many more markers have been identified in the human MHC. Some of them, 
which are located outside the MHC, may be useful to detect recombinations out-
side the HLA complex (Bach and van Rood, 1976). It may thus become possible 
to assess the relevance of parts of the chromosome outside the HLA complex 
for renal allograft survival. Except for PGM3 no such markers are yet identified 
in dogs. 
7 .4. Minor histocompatibility systems in dogs 
7.4.1. Relevance for renal allograft survival 
The experiments in non-sibling DLA matched beagles (chapter 5) suggest that 
the cumulative strength of non-MHC incompatibilities can be comparable in 
strength to MHC incompatibilities. This observation is in agreement with skin 
grafting experiments in mice (Graff et al., 1966). In that model, the cumulative 
effect of minor histocompatibility antigens appeared as strong as MHC differen-
ces in some MHC identical donor-recipient combinations. Such minor histo-
compatibility systems, each of which may be weak, become only important in 
the absence of other, stronger histocompatibility differences. Similar observa-
tions were done in a retrospective analysis of human related donor-recipient 
pairs by Opelz and Terasaki (1977e). They calculated that, in related donor-recip-
ient combinations, differences for minor histocompatibility antigens cause a 
15% kidney allograft failure rate within one year. Consequently it can be postu-
lated that the same minor histocompatibility differences would cause higher, 
maybe even 30%, yearly kidney allograft failure rates in unrelated individuals. 
The resulting 70% one year graft survival in MHC identical unrelated individuals 
would be equal to the observed one year graft survival in one haplotype different 
related donor-recipient pairs. This would be in perfect agreement with our exper-
iments in non-sibling beagles where kidney allograft survival was also compara-
ble to kidney allograft survival in one haplotype different related donor-recipient 
pairs (chapter 5). 
The similarity in the results obtained in beagles and humans is conspicuous in 
view of the differences between the experimental model and the clinical situ-
ation. In the first place, no immunosuppression is used in the beagle model, and 
no proof is available that non-MHC differences and MHC differences are equally 
well overcome by immunosuppression. In fact Silvers et al. (1967) found that 
the response to MHC antigens in rats was more difficult to control by immuno-
suppression than the response to non-MHC antigens. However, the general valid-
ity of the hypothesis, "that the weaker the antigens, the more easily immunosup-
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pression subdues recipient responsiveness", is questioned by Hildemann (1970), 
and no evidence is available that differences for weak histocompatibility systems 
can easily be suppressed if their cumulative effect is strong. Secondly, our recip-
ients did not receive blood transfusions prior to transplantation, in contrast to 
most human kidney recipients. This is an important point, as blood transfusions 
administered prior to renal allografting may have an important influence on 
renal allograft survival in man (Opelz et al., l974b; Persijn et al., 1977), rhesus 
monkeys (van Es et al., 1977) and dogs (Obertop et al., 1978). Thirdly, our dog 
recipients were not uremic at the time of transplantation, but it is unknown to 
what extent this point might influence the results. 
Thus, the similarity in results in beagles and humans can be caused by chance. 
New experiments in a more clinical set-up should provide more definite inform-
ation on the relevance of minor histocompatibility systems to renal allograft 
survival. 
7.4.2. Number of minor histocompatibility systems 
The number of minor histocompatibility systems and their alleles, which are in-
volved in the genetic control of renal allograft survival in beagles, appears to be 
relatively small (chapter 5). This is rather unexpected in view of the large num-
ber of minor histocompatibility systems that are reported to be involved in skin 
allograft survival in mice (Graff and Bailey, 1973 ). Two reasons however can be 
indicated here which may explain this difference. In the first place, the polymor-
phism in beagles may be limited as this is a selected breed; thus the number and 
polymorphism of minor histocompatibility systems may appear to be greater in 
mongrels for instance. Secondly, it may be that different minor histocompatibil-
ity systems are involved in the control of skin and kidney allograft survival. An 
indication for the existence of organ specific differences in dogs are the differen-
ces in survival times of DLA identical skin and kidney allografts (see also chapter 
I' § 1.7.). 
The effect of minor histocompatibility differences can be overcome by immu-
nosuppressive therapy. In addition, the administration of blood from third party 
blood donors to allograft recipients prior to transplantation considerably improv-
es renal allograft survival in dogs which are treated with immunosuppressive 
drugs (Obertop et al., !978). Therefore it will be important to study how many 
and which histocompatibility systems are important under those conditions. 
7.4.3. Matching for minor histocompatibility systems 
Compatibility for antigens of minor histocompatibility systems can theoretical-
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ly contribute to improved survival rates of renal homografts. Matching for such 
antigens can only be performed when techniques and reagents are available for 
the recognition of the gene products of the alleles of those systems. Several po-
lymorphic genetic systems are being recognized in the dog, such as erythrocyte 
antigens, canine secretory alloantigens (CSA), polymorphic erythrocyte and leu-
cocyte enzymes, serum proteins and non-DLA serologically defined leucocyte 
antigens (Joint Report of the Second International Workshop on Canine Immuno-
genetics, 1976). 
The CSA system has many similarities with the blood group ABO system in 
man (Zweibaum eta!., 1974). However, the ABO blood group antigens appeared 
to be important transplantation antigens (Starzl et al., 1964; van Hooff, 1976; 
Opelz and Terasaki, 1977f). No histocompatibility effect of the CSA system has 
sofar been demonstrated for graft versus host reactions in bone marrow trans-
plantation (Vriesendorp eta!., 1975b). A phenotypic difference for the enzyme 
marker PGM2 is correlated with a high incidence of graft versus host reactions in 
bone marrow transplantation in DLA identical dogs (Vriesendorp eta!., 1975b). 
Studies of CSA and PGM 2 with regard to renal allografting have not been per-
formed yet. Sex-linked histocompatibility systems appear to be of importance in 
immunized kidney allograft recipients (Vriesendorp et a!., 1978) but not in 
unimmunized recipients (chapter 5). 
The possibility that identity or difference for other markers can influence 
renal allograft survival, has as yet been insufficiently investigated (Vriesendorp 
et a!., 1977b). Furthermore, no systematic attempts have been made to produce 
reagents which can recognize minor histocompatibility antigens which are relev-
ant for renal allograft survival. One possible approach of this problem may be 
to select families, in which a short survival of DLA identical kidney allografts is 
seen. Repeated immunization with cells or tissues from DLA identical donors in 
such families may hopefully lead to the production of antisera which can help 
to identify non-MHC differences in those families. Thereafter, population studies 
with the obtained antisera should be performed to select DLA identical related 
and unrelated individuals which are matched and mismatched for the studied 
antigen. Finally renal allografts should be performed in such combinations to 
test the relevance of matching for the newly defined antigen for renal homograft-
ing. Evidently, the difficulty of the logistics of matching unrelated individuals 
increases with the number and polymorphism of the histocompatibility systems 
typed for. However, matching for such systems should be possible in beagles aft-
er the production of the necessary reagents as the number of important minor 
histocompatibility systems in that race is probably limited. It is possible, that 
under adequate immunosuppressive therapy, the number of relevant minor his-
tocompatibility systems is limited in man, as only I 0-15% of the HLA identical 
kidneys from living related donors are rejected. If this were to prove true, match-
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ing for minor histocompatibility systems should become feasible, provided 
that useful reagents can be produced. In the human situation matching for such 
systems might be especially helpful for recipients with rare HLA phenotypes 
for wrom HLA identical kidneys can not be found. 
7.5. Immune responsiveness 
7.5.1. "High and low responders" 
The one year survival rate of human kidney allografts derived from two HLA hap-
lotypes different sibling donors is about 50% (Opelz and Terasaki, 1977e). The 
overall one year survival rate of cadaver donor kidneys, regardless of HLA match-
ing, is also± 50% (Human Renal Transplant Registry, 13th report, 1977). Thus 
many kidneys function during long periods in spite of strong histocompatibility 
differences. In other words, some individuals respond to a renal homograft with 
a strong rejection reaction, while others do not. Doubtless, all or almost all of these 
allografts are rapidly rejected when the recipients are not treated with immuno-
suppressive drugs. Thus, high responders may be defined as individuals who do 
reject the transplanted kidney under immunosuppressive therapy after a short 
time, while low responders do not. 
7.5.2. Prospective identification of high and low responders 
A prospective identification of high and low responders would be of consider-
able clinical importance. In the first place, low responders could be given priority 
to high responders when enough kidneys are not available. Secondly, the donor 
selection practice would probably be different in both groups. High responders 
might profit more from HLA matching than low responders (van Hooff et al., 
1972; Opelz and Terasaki, 1973). Then high responders should wait for optim-
ally matched kidneys or preferably obtain a kidney from a HLA identical li-
ving related donor. In the third place, the needed dosage of immunosuppressive 
drugs would expected to be higher in high responders than in low responders. 
About 50% of the patients do not produce cytotoxic antibodies in spite of 
30 blood transfusions (Opelz et a!., 1973 ). Kidney allograft prognosis in patients 
with antibodies appears to be worse than in patients who do not produce anti-
bodies (van Hooff eta!., 1972; Opelz eta!., 1973). Thus patients who do prod-
uce antibodies after blood transfusions can be probably considered to be high res-
ponders. Patients who do reject the first transplanted kidney in a relatively short 
time, generally reject a second or third kidney after a short time as well. Thus, 
transplantation of a kidney is an excellent way to determine whether a patient 
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is a high responder or not (Opelz et al., 1976). Of course, it would be preferable 
to determine the responder status of a patient by in vitro tests beforehand. It 
seems that low in vitro reactivity of lymphocytes to PHA or allogeneic lympho-
cytes is correlated with a good renal allograft survival rate (Thomas et al., 1977; 
Opelz and Terasaki, 1977d). However, at present these tests do not yet allow an 
accurate prospective discrimination between high and low responders. 
7.5.3. Immune responsiveness and kidney allograft survival in dogs 
Fifteen kidneys transplanted to DLA identical non-sibling beagles were all reject-
ed within fifty days (chapter 5). In another experiment kidneys from DLA 
identical unrelated donors were transplanted to recipients which had permanent-
ly accepted a kidney from a DLA identical sibling donor. It would be expected 
that a second kidney, derived from a DLA identical donor and transplanted to 
such a long survivor, would be rejected within fifty days too. Contrary to this 
expectation, two out of five such second transplants were not rejected (own un-
published observations). Furthermore, skin allografts transplanted to these same 
two recipients and obtained from the second kidney donor, were not rejected 
either. No immunosuppression was used in these experiments. This is a remarkab-
le observation, as all other skin grafts transplanted in our laboratory, even from 
DLA identical siblings, were always rejected. The chances that the recipient and 
donor of the second kidney were identical for all relevant minor histocompatibil-
ity systems are small (chapter 5). Thus these animals can be probably consider-
ed to be "low responders" even though no immunosuppressive therapy was 
used. Such a low responder status is not necessarily an inherited quality. It is 
even possible that an active mechanism is involved, e.g. enhancement (see chap-
ter I, § 1.2.1.). However, a more aspecific mechanism might be suspected to 
play a role, as kidneys from different donors were permanently accepted by one 
recipient. Apparently this situation is comparable to the situation in man, where 
a good correlation between the survival times of first and subsequent kidney ho-
mografts is also reported (Opelz and Terasaki, 1976). 
After the administration of blood transfusions some dogs produce detectable 
cytotoxic antibodies, while others do not. A low antibody response was not 
clearly correlated with a prolonged renal allograft survival in dogs who did not 
receive immunosuppression (Bijnen et al., 1975b; Dull et al., 1978). However, in 
recipients with immunosuppression a correlation between antibody response 
and kidney allograft survival was found (Obertop et al., 1978). Thus a useful 
discrimination between low and high responders seems only possible when the 
recipients are treated with immunosuppressive drugs. 
Studies in which the in vitro immune responsiveness of lymphocytes to a 
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variety of antigens or mitogens is correlated with renal allograft survival in 
immunosuppressed dogs still have to be performed. 
7.5.4. Genetics of the immune response in dogs 
No systematic studies have been performed on the genetic background of the 
immune response against allografts in dogs. In fact it is uncertain, to what extent 
the responder status is an inherited or an acquired quality. Preliminary studies 
indicate that the immune responses against the copolymers of L-glutamic acid 
with L-alanine (GA), L-lysine (GL) and L-tyrosine (GT) are under control of ge-
nes linked to the DLA complex (Vriesendorp et al., 1977b). The role of these 
genes in transplantation immunity is unknown. A low immune response against 
GT does not necessarily imply prolonged kidney graft survival. On the contrary, 
in the experiment described in chapter 6, the GT non-responder rejected the kid-
ney much faster than the GT responder. 
The immune responsiveness to blood transfusions could be genetically deter-
mined (Bullet al., 1978). However, if this phenomenon is under genetic control, 
it is not governed by a simple Mendelian system linked to, or within, the DLA 
complex (Bijnen et al., 1975b; Bull et al., 1978). Thus it is likely that the respon-
se to a whole organ graft is at least as intricate. 
7.6. Non genetic influences on renal allograft survival 
Biologic variation plays an important role in kidney allograft survival in inbred 
rat strains (Tin bergen, 1971 ). Likewise, the biologic variation may be consider-
able in the dog model too. The preoperative administration of blood transfusions 
significantly prolongs renal allograft survival in immunosuppressed recipients 
(Obertop et al., 1978). This may be due to an aspeciftc effect of blood transfus-
ions; genetic factors are not known to play a part. The impact of immunosup-
pression on the different other factors influencing graft survival is incompletely 
known and may be complicated. Conclusions drawn from models where no im-
munosuppression is used are not necessarily valid for a similar model with im-
munosuppression. The addition of immunosuppressive drugs to experimental 
protocols however may induce other variables, as some dogs for example may be 
more sensitive for immunosuppressive drugs than others. These and other varia-
bles have to be taken into account when analyzing the results of allografting 
experiments. Variability however, can be minimized by conducting experiments 
in one laboratory under standard conditions in a standardized model. 
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7.7. Extrapolation to human kidney transplantation 
Extrapolation of observations in experimental animals to the human situation is 
hazardous. An exact imitation of the clinical situation in an animal model is im-
possible. Species specific differences may be the main reason that principles es-
tablished in an experimental animal are not applicable to man. However, if an 
experimental model has many similarities with the clinical situation, it becomes 
more likely, that additional observations in such a model have their analogues 
in man too. Especially when similar principles are uncovered in different pre-
clinical experimental animal models in quite distant species, for instance dogs 
and rhesus monkeys, it becomes likely that they are valid in man too. For in-
stance random blood transfusions, administered to recipients prior to transplant-
ation, considerably prolongs renal allograft survival in immunosuppressed rhe-
sus monkeys and dogs (vanEs et al., 1977; Obertop et al., 1978). These findings 
in both models probably justify the administration of blood to patients waiting 
for a renal allograft on dialysis. The dog model is immunogenetically in many 
respects similar to man (e.g. Vriesendorp et al., 1977b). Consequently observ-
ations in this model may very well be valid for man too. 
Extrapolation of the observations in this thesis implies that when a choice can be 
made from different living related donors, an MHC identical donor should be select-
ed. If the recipient has a recombination within the MHC, an MLR identical donor 
should be chosen. For cadaver kidney transplantation HLA-D identical donor-re-
cipient pairs are to be preferred. The selection of completely MLR identical 
unrelated individuals will be difficult because of the complex genetic con-
trol of the MLR. For a further improvement of kidney survival rates attempts 
should be undertaken to match for non-HLA histocompatibility systems, which 
may appear very important in unrelated donor-recipient combinations. 
The overall result of histocompatibility matching is not only determined by 
the improvement in kidney survival rates procured by a better match grede, but 
is also dependent on the fraction of the recipient pool which can profit of such 
a better match grade. Well matched recipients for each donor are more likely to 
be found in larger recipient pools. Thus the effectiveness of histocompatibility 
matching programms can be improved by extending these recipient pools. In larg-
er geographical areas however a greater heterogeneity of genetic systems may 
be expected. Thus when kidneys are distributed over larger geographical areas, 
identification of still undefined histocompatibility systems becomes even more 
important. Methods for the identification of such systems may be developed in 
an experimental animal as the dog. 
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7 .8. Future histocompatibility research in the dog 
To obtain a more complete insight into the genetic factors which are relevant for 
renal transplantation the following subjects should be taken under study: 
a) development of B cell typing and PLT in dogs 
b) development of methods for the identification of minor histocompatibility 
structures 
c) development of methods for the prospective identification of high and low 
responders 
d) testing the relevance of matching for the different histocompatibility systems 
for renal allograft survival in recipients under immunosuppressive therapy 
e) analysis of the factors which cause a prolonged kidney allograft survival in re-
cipients which received blood transfusions prior to transplantation, and 
f) testing the relevance of matching for the different histocompatibility systems 
for renal allograft survival in immunosuppressed recipients which received 
blood transfusions prior to transplantation. 
It has become obvious that the most rapid way to define optimal conditions for 
organ allografting is to intensify transplantation research in immunologically 
well defined experimental animals. Some of these studies are in progress in our 
laboratory. However, it is clear, that the formidable task outlined above, is too 
large for one laboratory. Joint efforts of several laboratories with a co-ordinated 
programm are required to complete this duty. 
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SUMMARY 
The fate of a transplanted organ is dependent, among other factors, on the anti-
genic differences between organ donor and recipient. Selection of compatible 
donor-recipient combinations is done by means of tissue-typing. 
In chapter I the basic aspects of the technique and the genetics of two differ-
ent tissue-typing methods, namely a serologic method, the lymphocytotoxicity 
test and a cell culture method, the mixed lymphocyte reaction (MLR), are review-
ed. It appears from the literature on human kidney transplantation that a good 
correlation between renal allograft survival rates and serological compatibility is 
found when donor and recipient are related. The correlation between kidney 
homograft survival rates and serological match grade is less good when donor 
and recipient are not related. Most authors report that kidneys from MLR com-
patible donors do significantly better than kidneys from MLR incompatible 
donors. However a precise evaluation of the value of matching for MLR antigens 
is hampered by the retrospective character of most studies and the fact that dif-
ferent MLR techniques and criteria have been used. Furthermore, the correlation 
between kidney allograft survival and compatibility for MLR is not complete, as 
some kidneys do well in spite of a strongly positive MLR, while some other 
kidneys, derived from MLR compatible donors, are rejected in a short time. In 
most experimental studies in animals and man a positive correlation between 
MLR compatibility and allograft survival is found. 
The purpose of the experiments described in this thesis was to obtain a more 
accurate insight into the possible role of matching for MLR antigens and other 
antigens for donor selection for renal transplantation. The dog was chosen as an 
experimental animal because of its immunogenetical similarities to man and the 
extensive knowledge, which is available on its major histocompatibility complex 
(MHC). 
A more extensive description of the used techniques is presented in chapter 
2. The technique which was used for the MLR is described extensively, as the 
MLR has a central role in the studies reported in this thesis. 
For an optimal evaluation of the correlation between MLR compatibility 
and organ allograft prognosis, knowledge of the kinetics of the MLR is required. 
The outcome of the MLR is dependent on the genetic disparity between the two 
tested individuals, but more variables determine the test result. In chapter 3 the 
influence of variation of the used numbers of responder cells, stimulator cells, 
and of the responder/stimulator cell ratio is studied in genetically different cell 
113 
combinations. The number of responder and stimulator cells and their ratio 
which produces an optimal stimulation in MLR appear to be independent of the 
genetic disparity between the stimulator and responder cells. The optimal cult-
ure length is variable too. It appears to be shorter in unrelated cell combinations. 
The observed variability hampers a quantitative interpretation of the test; for a 
quantitative interpretation a short culture length should be chosen (4 or 5 days); 
however when such a short culture length was used, false negative results were 
sometimes obtained. 
The genes which determine the outcome of the MLR are located within the 
MHC. The recombination frequency between the MLR genes and the serolog-
ically defined genes of the canine MHC is estimated to be 0.007 (chapter 4 ). The 
calculation of this estimate is based on the assumption that the canine MHC con-
tains only one MLR locus. It is argued, however, that the canine MHC probably 
contains at least two MLR loci. Presently eleven different homozygous reference 
cells are available to type for the products of the MLR genes. illdividuals which 
are identical for the MLR antigens according to MLR typing frequently stimu-
late each other in MLR, although less frequent than individuals with a different 
MLR typing. Consequently this typing method with homozygous reference cells 
appears not very useful for donor selection. 
ill chapters 5 and 6 the results are presented of renal allografting experi-
ments in dogs in various genetically different donor-recipient combinations. Im-
munosuppressive drugs were not used. It appears that not only MHC systems 
detennine the outcome of renal allograft survival. Important non-MHC systems 
must be assumed which also influence graft survival. ill the beagle, the number 
of non-MHC systems and their polymorphism seems to be small. Within the 
MHC, the subregions which contain the MLR genes play a predominant role in 
the genetic control of kidney allograft survival. This is apparent from the renal 
allografting experiments with related beagles in which the donor or recipient has 
a recombination in the MHC. Furthermore, in mongrels a prolonged graft sur-
vival is only observed in MLR compatible donor-recipient combinations; com-
patibility for serologically defined antigens alone has no favourable influence on 
graft survival. 
In chapter 7 (general discussion), the different factors which together deter-
mine the ultimate fate of a transplanted kidney are reviewed. Histocompatibility 
differences are very important. The impact of a number of different methods 
for the determination of histocompatibility differences is discussed. Many anti-
gens are important for graft survival, but only some of them are presently defin-
ed. ill the dog only the importance of MLR antigens for allograft survival has 
been demonstrated. A direct MLR between donor and recipient is presently the 
only reliable method for the selection ofMLR compatible dogs. The number and 
polymorphism of the undefined histocompatibility antigens in beagles may be 
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small. Therefore it is attractive to develop methods to type for these antigens. 
As the dog is immunogenetically very similar to man, it is probable that match-
ing for these non-MHC systems can improve transplant survival rates in man too. 
Some individuals react more strongly to histocompatibility differences than 
others. Prospective identification of "responders" would be an additional 
approach to improve the results of kidney transplantation programms. In vitro 
methods for such a prospective identification of responders are not yet available 
in dogs. 
The results described in this thesis demonstrate that in unrelated unimmuno-
suppressed dogs kidney allograft survival times can be improved by the selection 
of an MLR compatible donor. A detailed knowledge of the kinetics and the 
genetics of the MLR in dogs as described in this thesis may lead to a more op-
timal selection procedure. For a further improvement of kidney allograft sur-
vival times attempts should be undertaken to match for other, presently unde-
fined, histocompatibility systems, which in part do not belong to the MHC. 
Additional studies have to be performed to determine whether the observ-
ations obtained in an experimental model without immunosuppression can be 
extrapolated to models with immunosuppression and the clinical situation. 
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SAME NV A TTING 
De prognose van een getransplanteerd orgaan is beter naarrnate de antigene 
structuur van het transplantaat beter overeen komt met dat van de ontvanger. 
Selectie van passende donor-ontvanger combinaties geschiedt door middel van 
weefseltypering. 
In hoofdstuk I worden de basale technische en genetische aspecten van twee 
vormen van weefseltypering, namelijk door middel van serologisch onderzoek en 
door mid del van gemengde lymphocyten kweken (mixed lymphocyte reactions, 
MLR's) besproken. Uit de literatuur blijkt dater bij de mens een goede correlatie 
bestaat tussen niertransplantaat overleving en serologische compatibiliteit, 
wanneer donor en ontvanger verwant zijn. Wanneer donor en ontvanger niet 
verwant zijn is dit in vee! mindere mate het geval. De meeste auteurs vinden dat 
compatibiliteit voor MLR leidt tot een significant betere transplantaatoverle-
ving. Een nauwkeurige evaluatie van het belang van compatibiliteit voor MLR 
antigenen wordt bemoeilijkt door het retrospectieve karakter van de meeste 
studies en het gebruik van verschillende technieken en criteria. De correlatie is 
voorts niet absoluut, aangezien lange transplantaatoverlevingen worden gevon-
den ondanks een duidelijke incompatibiliteit voor MLR en daarnaast MLR com-
patibele nieren soms snel worden afgestoten. In de rneeste experimentele onder-
zoeken bij dieren en mensen wordt echter wel een positieve correlatie gevonden 
tussen MLR compatibiliteit en transplantaatoverleving. 
Het onderzoek dat in dit proefschrift wordt beschreven, heeft tot doe! inzicht te 
verkrijgen in de mogelijke rol, welke "matching" voor MLR antigenen en andere 
antigenen kan spelen bij donorselectie voor niertransplantatie. Het proefdier dat 
gebruikt werd, is de hond, omdat er een uitgebreide kennis bestaat van het 
"Hoofd Histocompatibiliteits Complex" (Major Histocompatibility Complex, 
MHC) van de hond en dit proefdier in immunogenetisch opzicht vee! overeen-
komsten vertoont met de mens. De gebruikte technieken worden meer in detail 
beschreven in hoofdstuk 2, met name de technische uitvoering van de MLR, om-
dat deze in dit proefschrift een centrale rol speelt. 
Voor een optimale evaluatie van de relatie tussen MLR compatibiliteit en 
transplantaatprognose is kennis van de kinetica van die test gewenst. De uit-
komst van de MLR is, behalve van het genetisch verschil tussen !wee individuen, 
afhankelijk van een aantal variabclen. In hoofdstuk 3 wordt de studie beschre-
vcn, waarbij de invloed van variatie van het gebruikte aantal respondercellen, 
het gcbruiktc aantal stimulatorcellen en de verhouding tussen deze twee celpo-
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pulaties wordt onderzocht in genetisch verschillende combinaties. Het aantal 
responder- en stimulatorcellen en hun ratio, waarbij een optimaal resultaat wordt 
bereikt, blijkt variabel en niet duidelijk afhankelijk van de genetische verschillen 
tussen stimulator- en respondercellen. De optirnale kweekduur is oak variabel en 
lijkt korter in onverwante combinaties. De gevonden variabiliteit bemoeilijkt 
een kwantitatieve interpretatie van de test; deze is waarschijnlijk het meest be-
trouwbaar bij een korte kweekduur, bijvoorbeeld 4 of 5 dagen; soms wordt bij 
een zo korte kweekduur echter een vals negatieve uitslag verkregen. 
De MLR genen maken dee! uit van het MHC. De recombinatiefrequentie !us-
sen de MLR genen en de serologisch gedefinieerde genen van het MHC van de 
hand wordt geschat op 0.007 (hoofdstuk 4 ). Bij de berekening van deze schat-
ting werd ervan uitgegaan dat zich in het MHC van de hand slechts een belang-
rijk MLR locus bevindt. Het MHC telt echter waarschijnlijk tenminste twee MLR 
loci. Momenteel zijn er elf verschillende homozygote referentiecellen beschik-
baar om te typeren voor de producten van de MLR genen. lndividuen met een 
identieke "MLR typering" stimuleren elkaar minder vaak in MLR dan individuen 
met een verschillende "MLR type ring", maar de MLR is tach vaak positief. Het 
nut van de genoemde typeringsmethode met homozygote typeercellen voor do-
norselectie lijkt dus betrekkelijk. 
In de hoofdstukken 5 en 6 worden de resultaten beschreven van enkele 
niertransplantaat-experimenten in een aantal genetisch verschillende donor-ont-
vanger combinaties bij honden. Geen immunosuppressieve middelen werden toe-
gediend. Het blijkt dat men moet veronderstellen dat er buiten het MHC oak 
andere genetische systemen aanwezig moeten zijn, die de transplantaatoverle-
ving in belangrijke mate bei'nvloeden. In de beagle lijkt het aantal van deze non-
MHC systemen en hun polymorfisme beperkt. Binnen het MHC zijn de subre-
gionen, die de MLR genen bevatten, van predominant belang voor de transplan-
taatprognose. Dit blijkt uit de transplantaatoverlevingen van verwante donor-
ontvanger comb ina ties, waarvan donor of ontvanger een recomb ina tie in de MHC 
heeft. Bovendien wordt bij onverwante bastaarden alleen een verlenging van de 
transplantaatoverleving gezien indien donor en ontvanger MLR compatibel zijn, 
en niet wanneer zij alleen serologisch compatibel zijn. 
In hoofdstuk 7, de algemene discussie, worden de verschillende factoren, wel-
ke het uiteindelijk al of niet slagen van een transplantatie bepalen, besproken. 
Histocompatibiliteitsverschillen zijn zeer belangrijk. Het belang van verschillende 
in vitro methodes om histocompatibiliteitsverschillen aan te tonen wordt bedis-
cussieerd. Van de vele voor transplantatie belangrijke antigenen kunnen er slechts 
enkele worden her ken d. Bij de hand is aileen het belang van compatibiliteit voor 
MLR antigen en voor transplantatie aangetoond. Voorlopig is de enige betrouwbare 
methode om MLR identieke individuen te selecteren de directe MLR tussen do-
nor en ontvanger zelf. Omdat in beagles het aantal voor transplantatie belangrij-
118 
ke niet gedefinieerde antigenen mogelijk klein is, is he! aantrekkelijk methoden 
te ontwikkelen om deze te bepalen. Aangezien de hond in immunogenetisch op-
zicht vee! overeenkomsten vertoont met de mens lijkt he! waarschijnlijk dat ook 
bij de mens matching voor deze non-MHC systemen de transplantaatprognose 
zal kunnen verbeteren. Sommige individuen reageren sterker op histocompatibili-
teitsverschillen dan anderen. Prospectieve identificatie van "responders" zou een 
andere manier zijn om de resultaten van niertransplantatie te verbeteren. In vitro 
methodes voor zo'n prospectieve identificatie van responders zijn echter nog niet 
beschikbaar in de hond. 
De resultaten beschreven in dit proefschrift, tonen dat, althans in het honden-
model zonder immunosuppressie, de transplantaatprognose in onverwante do-
nor-ontvanger comb ina ties verbeterd kan worden door een MLR passende donor 
te zoeken. Een gedetailleerde kennis van de kinetica en de genetica van de MLR 
zoals deze in dit proefschrift word! beschreven kan bijdragen tot het ontwikke-
len van efficientere selectieprocedures. Om de transplantaatprognose verder te 
verbeteren moet geprobeerd worden om te "matchen" voor andere nog ongede-
finieerde histocompatibiliteitssystemen. Dit zijn niet aileen nog ongedefinieerde 
systemen welke behoren tot het MHC, maar ook andere systemen, welke niet 
behoren tot het MHC. 
Verder onderzoek is noodzakelijk om na te gaan in hoeverre de bevindingen 
in een model zonder imrnunosuppressie geextrapoleerd kunnen worden naar 
modellen waarin wei immunosuppressiva gebruikt worden en naar de klinische 
situatie. 
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